<SEC-DOCUMENT>0001839882-25-071122.txt : 20251215
<SEC-HEADER>0001839882-25-071122.hdr.sgml : 20251215
<ACCEPTANCE-DATETIME>20251215155007
ACCESSION NUMBER:		0001839882-25-071122
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20251215
DATE AS OF CHANGE:		20251215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BANK OF NOVA SCOTIA
		CENTRAL INDEX KEY:			0000009631
		STANDARD INDUSTRIAL CLASSIFICATION:	STATE COMMERCIAL BANKS [6022]
		ORGANIZATION NAME:           	02 Finance
		EIN:				134941099
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-282565
		FILM NUMBER:		251571434

	BUSINESS ADDRESS:	
		STREET 1:		40 TEMPERANCE STREET
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5H 0B4
		BUSINESS PHONE:		(416) 866-3672

	MAIL ADDRESS:	
		STREET 1:		40 TEMPERANCE STREET
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5H 0B4

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BANK OF NOVA SCOTIA /
		DATE OF NAME CHANGE:	19970702
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>bns_424b2-41505.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
    <HEAD>
        <TITLE></TITLE>
<!-- QES 7h3d0c70r 1765515665.0657954 -->
    </HEAD>
    <BODY style="text-decoration-skip-ink: none; ">

        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.54pt; padding: 38.83pt 38.83pt 0 38.83pt; min-height: 10.00pt; position: relative; ">
                <DIV style="text-align: center; ">
                    <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; margin: 0 auto; ">
                        <TR>
                            <TD width="195.75pt" style="width: 195.75pt; border: 0; margin: 0; padding: 0; height: 0; ">
                            </TD>
                            <TD width="187.99pt" style="width: 187.99pt; border: 0; margin: 0; padding: 0; height: 0; ">
                            </TD>
                            <TD width="211.26pt" style="width: 211.26pt; border: 0; margin: 0; padding: 0; height: 0; ">
                            </TD>
                        </TR>
                        <TR style="vertical-align: top; ">
                            <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 7.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
                            </TD>
                            <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 7.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
                            </TD>
                            <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                                <P style="line-height: 1.35; text-align: right; margin-top: 0; margin-bottom: 0; "><FONT style="font-weight: bold; font-size: 7.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Filed Pursuant to Rule 424(b)(2)</font><BR><font style='white-space: pre-wrap;'>Registration Statement No. 333-282565</font><BR><font style='white-space: pre-wrap;'>(To Prospectus dated November 8, 2024,</font><BR><font style='white-space: pre-wrap;'>Prospectus Supplement dated November 8, 2024</font><BR><font style='white-space: pre-wrap;'>and Product Supplement EQUITY STR-1 dated November 8, 2024)</font></FONT></P>
                            </TD>
                        </TR>
                    </TABLE>
                </DIV>

            </DIV>
            <DIV style="width: 595.54pt; padding: 10pt 38.83pt 10pt 38.83pt; position: relative; margin-bottom: 20pt; ">
                <TABLE width="100.00%" style="margin-left: 0pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="28.27%" style="width: 28.27%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="27.90%" style="width: 27.90%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="26.97%" style="width: 26.97%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="0.20%" style="width: 0.20%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="26.66%" style="width: 26.66%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="0.00%" style="width: 0.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="0.02%" style="width: 0.02%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD colspan="2" rowspan="2" style="padding-top: 0.0pt; padding-left: 9.90pt; padding-right: 6.33pt; padding-bottom: 0.0pt; background-color: #1F497D; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="color: #FFFFFF; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>839</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "></FONT><FONT style="color: #FFFFFF; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>,142 Units</font><BR><font style='white-space: pre-wrap;'>$10 principal amount per unit</font><BR><font style='white-space: pre-wrap;'>CUSIP No. 06419E846</font><BR>                                    <IMG width="253.99pt" height="35.92pt" src="image1.gif" style="width: 253.99pt; height: 35.92pt; ">
                                    </FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 9.90pt; padding-right: 6.33pt; padding-bottom: 0.0pt; background-color: #1F497D; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="color: #FFFFFF; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Pricing Date</font><BR><font style='white-space: pre-wrap;'>Settlement Date</font><BR><font style='white-space: pre-wrap;'>Maturity Date</font></FONT></P>
                        </TD>
                        <TD colspan="3" style="padding-top: 0.0pt; padding-left: 6.33pt; padding-right: 6.33pt; padding-bottom: 0.0pt; background-color: #1F497D; ">
                            <P style="text-align: right; margin-top: 0; margin-bottom: 0; "><FONT style="color: #FFFFFF; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>December 11, 2025</font></FONT></P>
                            <P style="text-align: right; margin-top: 0; margin-bottom: 0; "><FONT style="color: #FFFFFF; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>December 18, 2025</font></FONT></P>
                            <P style="text-align: right; margin-top: 0; margin-bottom: 0; "><FONT style="color: #FFFFFF; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD colspan="3" style="padding-top: 0.0pt; padding-left: 9.90pt; padding-right: 6.33pt; padding-bottom: 0.0pt; background-color: #1F497D; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="color: #FFFFFF; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
                        </TD>
                        <TD colspan="2">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 3.30pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 9.90pt; padding-right: 6.33pt; padding-bottom: 0.0pt; background-color: #046E87; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="color: #FF0000; font-size: 1.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 6.33pt; padding-right: 6.33pt; padding-bottom: 0.0pt; background-color: #C87D0E; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="color: #FF0000; font-size: 1.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 6.33pt; padding-right: 6.33pt; padding-bottom: 0.0pt; background-color: #5C255C; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="color: #FF0000; font-size: 1.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
                        </TD>
                        <TD colspan="3" style="padding-top: 0.0pt; padding-left: 6.33pt; padding-right: 6.33pt; padding-bottom: 0.0pt; background-color: #61961A; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="color: #FF0000; font-size: 1.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
                        </TD>
                        <TD>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 176.11pt; ">
                        <TD colspan="5" style="padding-top: 0.0pt; padding-left: 9.90pt; padding-right: 6.33pt; padding-bottom: 0.0pt; background-color: #1F497D; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-weight: bold; color: #FFFFFF; font-size: 21.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-weight: bold; color: #FFFFFF; font-size: 19pt; vertical-align: super; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-weight: bold; color: #FFFFFF; font-size: 21.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'> Linked to the Global X Uranium ETF</font></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 0.0pt; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Automatically callable if the Observation Level on any Observation Date, occurring approximately one, two, three, four and five years after the pricing date, is at or above the Starting Value</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 0.0pt; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>In the event of an automatic call, the amount payable per unit will be:</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 0.0pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>$11.461 if called on the first Observation Date</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 0.0pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>$12.922 if called on the second Observation Date</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 0.0pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>$14.383 if called on the third Observation Date</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 0.0pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>$15.844 if called on the fourth Observation Date</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 0.0pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>$17.305 if called on the final Observation Date</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 0.0pt; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>If not called on any of the first four Observation Dates, a maturity of approximately five years</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 0.0pt; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>If not called but the Underlying Fund does not decline by more than 15.00%</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>,</font></FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'> a return of principal</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 0.0pt; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>If not called, 1-to-1 downside exposure to decreases in the Underlying Fund beyond a 15.00% decline, with up to 85.00% of your principal amount at risk</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 5.5pt; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>All payments are subject to the credit risk of The Bank of Nova Scotia</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 5.5pt; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>No periodic interest payments</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 5.5pt; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>In addition to the underwriting discount set forth below, the notes include a hedging-related charge of $0.05 per unit. See &#8220;Structuring the Notes&#8221;</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 5.5pt; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Limited secondary market liquidity, with no exchange listing</font></FONT></FONT></P>
                            <P style="margin-top: 5.5pt; margin-bottom: 5.5pt; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #FFFFFF; font-size: 8.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="color: #FFFFFF; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>The notes are unsecured debt securities and are not savings accounts or insured deposits of a bank. The notes are not insured or guaranteed by the Canada Deposit Insurance Corporation (the &#8220;CDIC&#8221;), the U.S. Federal Deposit Insurance Corporation (the &#8220;FDIC&#8221;), or any other governmental agency of Canada, the United States or any other jurisdiction</font></FONT></FONT></P>
                        </TD>
                        <TD colspan="2">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 4.46pt; ">
                        <TD colspan="5" style="padding-top: 0.0pt; padding-left: 9.90pt; padding-right: 6.33pt; padding-bottom: 0.0pt; background-color: #B8CCE4; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; color: #FFFFFF; font-size: 5.0pt; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
                        </TD>
                        <TD colspan="2">
                        </TD>
                    </TR>
                </TABLE>
                <P style="margin-top: 6.6pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-weight: bold; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>The notes are being issued by The Bank of Nova Scotia (&#8220;BNS&#8221;). There are important differences between the notes and a conventional debt security, including different investment risks and certain additional costs. See &#8220;Risk Factors&#8221; beginning on page TS-7 of this term sheet, &#8220;Additional Risk Factors&#8221; on page TS-8 of this term sheet and &#8220;Risk Factors&#8221; beginning on page PS-7 of product supplement EQUITY STR-1.</font></FONT></P>
                <P style="margin-top: 0.0pt; margin-bottom: 1.5pt; text-align: justify; "><FONT style="font-weight: bold; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>The initial estimated value of the notes as of the pricing date is $9.05 per unit, which is less than the public offering price listed below.</font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'> See &#8220;Summary&#8221; on the following page, &#8220;Risk Factors&#8221; beginning on page TS-7 of this term sheet and &#8220;Structuring the Notes&#8221; on page TS-15 of this term sheet for additional information. The actual value of your notes at any time will reflect many factors and cannot be predicted with accuracy.</font></FONT></P>
                <P style="margin-top: 1.5pt; margin-bottom: 1.5pt; text-align: center; "><FONT style="font-weight: bold; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>_________________________</font></FONT></P>
                <P style="margin-top: 1.5pt; margin-bottom: 1.5pt; text-align: justify; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>None of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), any state securities commission, or any other regulatory body has approved or disapproved of these notes or determined if this Note Prospectus (as defined below) is truthful or complete. Any representation to the contrary is a criminal offense.</font></FONT></P>
                <P style="margin-top: 1.5pt; margin-bottom: 9.9pt; text-align: center; "><FONT style="font-weight: bold; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>_________________________</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: auto; width: 100.00%; table-layout: fixed; border-collapse: collapse; margin-right: auto; ">
                    <TR>
                        <TD width="45.34%" style="width: 45.34%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="28.67%" style="width: 28.67%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="35.99%" style="width: 35.99%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; text-decoration-style: solid; text-decoration-line: underline; font-family: Arial, sans-serif; "><U><font style='white-space: pre-wrap;'>Per Unit</font></U></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; text-decoration-style: solid; text-decoration-line: underline; font-family: Arial, sans-serif; "><U><font style='white-space: pre-wrap;'>Total</font></U></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Public offering </font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>price</font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; width: 87.78pt; display: inline-block; ">&nbsp;</FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>$</font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; width: 8.58pt; display: inline-block; ">&nbsp;</FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>10.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>$8,391,420.00</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Underwriting </font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>discount</font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; width: 80.52pt; display: inline-block; ">&nbsp;</FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>$</font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; width: 13.86pt; display: inline-block; ">&nbsp;</FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>0.20</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>$167,828.40</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Proceeds, before expenses, to </font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>BNS</font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; width: 25.08pt; display: inline-block; ">&nbsp;</FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>$</font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; width: 13.86pt; display: inline-block; ">&nbsp;</FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>9.80</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>$8,223,591.60</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-indent: -50.99pt; padding-left: 50.99pt; text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes:</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: auto; width: 100.00%; table-layout: fixed; border-collapse: collapse; margin-right: auto; ">
                    <TR>
                        <TD width="36.48%" style="width: 36.48%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="37.53%" style="width: 37.53%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="35.97%" style="width: 35.97%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Are Not FDIC Insured</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Are Not Bank Guaranteed</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="text-align: center; margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>May Lose Value</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
            </DIV>
            <DIV style="width: 595.54pt; padding: 0 38.83pt 22.99pt 38.83pt; min-height: 23.76pt; position: relative; ">
                <P style="text-align: center; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 14.0pt; "><font style='white-space: pre-wrap;'>BofA Securities</font></FONT></P>
                <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: normal; font-size: 10.0pt; "><font style='white-space: pre-wrap;'>December 11, 2025</font></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Summary</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>The Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-size: 6pt; vertical-align: super; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'> Linked to the Global X Uranium ETF due December 30, 2030 (the &#8220;notes&#8221;) are our senior unsecured debt securities. The notes are not guaranteed or insured by the CDIC or the FDIC, and are not, either directly or indirectly, an obligation of any third party. The notes are not bail-inable debt securities (as defined in the prospectus).</font></FONT><FONT style="font-weight: bold; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'> The notes will rank equally with all of our other unsecured senior debt. Any payments due on the notes, including any repayment of principal, will be subject to the credit risk of BNS.</font></FONT><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'> The notes will be automatically called at the applicable Call Amount if the Observation Level of the Market Measure, which are the shares of the Global X Uranium ETF (the &#8220;Underlying Fund&#8221;), on any Observation Date is equal to or greater than the Call Level. If the notes are not called, at maturity, if the Ending Value is less than the Starting Value but greater than or equal to the Threshold Value, you will receive the principal amount of your notes. If, however, the notes are not called and the Ending Value is less than the Threshold Value, you will lose a portion, which could be significant, of the principal amount of your notes. Payments on the notes will be calculated based on the $10 principal amount per unit and will depend on the performance of the Underlying Fund, subject to our credit risk. See &#8220;Terms of the Notes&#8221; below.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>The economic terms of the notes (including the Call Premiums and Call Amounts) are based on our internal funding rate, which is the rate we would pay to borrow funds through the issuance of market-linked notes, and the economic terms of certain related hedging arrangements. Our internal funding rate is typically lower than the rate we would pay when we issue conventional fixed rate debt securities. This difference in funding rate, as well as the underwriting discount and the hedging related charge described below, reduced the economic terms of the notes to you and the initial estimated value of the notes on the pricing date. Due to these factors, the public offering price you pay to purchase the notes is greater than the initial estimated value of the notes.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>On the cover page of this term sheet, we have provided the initial estimated value for the notes. The initial estimated value was determined by reference to our internal pricing models, which take into consideration certain factors, such as our internal funding rate on the pricing date and our assumptions about market parameters. For more information about the initial estimated value and the structuring of the notes, see &#8220;Structuring the Notes&#8221; on page TS-15.</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: auto; width: 100.00%; table-layout: fixed; border-collapse: collapse; margin-right: auto; ">
                    <TR>
                        <TD width="15.53%" style="width: 15.53%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="32.21%" style="width: 32.21%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="62.26%" style="width: 62.26%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; "><FONT style="font-size: 20.0pt; color: #5B862B; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Terms of the Notes</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; "><FONT style="font-size: 20.0pt; color: #5B862B; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Payment Determination</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 15.35pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Issuer:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>The Bank of Nova Scotia (&#8220;BNS&#8221;)</font></FONT></P>
                        </TD>
                        <TD rowspan="15" style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0.0pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 12.0pt; font-weight: bold; "><font style='white-space: pre-wrap;'>Automatic Call Provision:</font></FONT></P>
                            <P style="margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">                                    <IMG width="291.06pt" height="156.61pt" src="image2.gif" style="width: 291.06pt; height: 156.61pt; ">
                                    </FONT></P>
                            <P style="margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 12.0pt; font-weight: bold; "><font style='white-space: pre-wrap;'>Redemption Amount Determination:</font></FONT></P>
                            <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>If the notes are not called, you will receive the Redemption Amount per unit on the maturity date, determined as follows:</font></FONT></P>
                            <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">                                    <IMG width="325.05pt" height="186.62pt" src="image3.jpg" style="width: 325.05pt; height: 186.62pt; ">
                                    </FONT></P>
                            <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-weight: bold; font-style: italic; font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>In this case you will receive a Redemption Amount that is less, and possibly significantly less, than the Principal Amount per unit.</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Principal Amount:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$10.00 per unit</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Term:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Approximately five years, if not called on any of the first four Observation Dates</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Market Measure:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>The Global X Uranium ETF (Bloomberg symbol: &#8220;URA&#8221;) </font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Starting Value:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$49.00</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Observation Level:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>The Closing Market Price of the Market Measure on the applicable Observation Date multiplied by the Price Multiplier</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Ending Value:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>The Observation Level of the Underlying Fund on the final Observation Date</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Price Multiplier:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>1, subject to adjustment for certain events relating to the Underlying Fund, as described beginning on page PS-29 of product supplement EQUITY STR-1.</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Observation Dates:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>December 18, 2026, December 23, 2027, December 22, 2028, December 21, 2029 and December 20, 2030 (the final Observation Date).</font></FONT></P>
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>The Observation Dates are subject to postponement in the event of Market Disruption Events, as described on page PS-26 of product supplement EQUITY STR-1.</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Call Level:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$49.00 (100.00% of the Starting Value)</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Call Amounts (per Unit) and Call Premiums:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$11.461, representing a Call Premium of 14.61% of the principal amount, if called on the first Observation Date, $12.922, representing a Call Premium of 29.22% of the principal amount, if called on the second Observation Date, $14.383, representing a Call Premium of 43.83% of the principal amount, if called on the third Observation Date, $15.844, representing a Call Premium of 58.44% of the principal amount, if called on the fourth Observation Date and $17.305, representing a Call Premium of 73.05% of the principal amount, if called on the final Observation Date. </font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>2</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <TABLE width="100.00%" style="margin-left: auto; width: 100.00%; table-layout: fixed; border-collapse: collapse; margin-right: auto; ">
                    <TR>
                        <TD width="15.53%" style="width: 15.53%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="32.21%" style="width: 32.21%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="62.26%" style="width: 62.26%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Call </font></FONT><FONT style="font-family: Arial, sans-serif; font-weight: normal; color: black; font-size: 8.0pt; "></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Settlement Dates:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Approximately the fifth business day following the applicable Observation Date, subject to postponement as described on page PS-24 of product supplement EQUITY STR-1; provided however that the Call Settlement Date related to the final Observation Date will be the maturity date.</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Threshold Value:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$41.65 (85.00% of the Starting Value)</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Fees and Charges:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>The underwriting discount of $0.20 per unit listed on the cover page and the hedging related charge of $0.05 per unit described in &#8220;Structuring the Notes&#8221; on page TS-15.</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; background-color: #F2F2F2; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; font-weight: bold; color: #5B8F22; "><font style='white-space: pre-wrap;'>Calculation Agent:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>BofA Securities, Inc. (&#8220;BofAS&#8221;)</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>3</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The terms and risks of the notes are contained in this term sheet and in the following:</font></FONT></P>
                <P style="margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Product supplement EQUITY STR-1 dated November 8, 2024:</font><BR></FONT><A href="http://www.sec.gov/Archives/edgar/data/9631/000183988224038321/bns_424b2-21312.htm" style="word-break: break-all; "><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; color: #0000FF; text-decoration-style: solid; text-decoration-line: underline; "><U><font style='white-space: pre-wrap;'>http://www.sec.gov/Archives/edgar/data/9631/000183988224038321/bns_424b2</font></U><U><font style='white-space: pre-wrap;'>-</font></U><U><font style='white-space: pre-wrap;'>21312.htm</font></U></FONT></A><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'> </font></FONT></FONT></P>
                <P style="margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Prospectus supplement dated November 8, 2024:</font><BR></FONT><A href="http://www.sec.gov/Archives/edgar/data/9631/000183988224038303/bns_424b3-21311.htm" style="word-break: break-all; "><FONT style="font-family: Arial, sans-serif; color: #0000FF; text-decoration-style: solid; text-decoration-line: underline; font-size: 9.0pt; "><U><font style='white-space: pre-wrap;'>http://www.sec.gov/Archives/edgar/data/9631/000183988224038303/bns_424b3</font></U><U><font style='white-space: pre-wrap;'>-</font></U><U><font style='white-space: pre-wrap;'>21311.htm</font></U></FONT></A></FONT></P>
                <P style="margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Prospectus dated November 8, 2024:</font><BR></FONT><A href="http://www.sec.gov/Archives/edgar/data/9631/000119312524253771/d875135d424b3.htm" style="word-break: break-all; "><FONT style="font-family: Arial, sans-serif; color: #0000FF; text-decoration-style: solid; text-decoration-line: underline; font-size: 9.0pt; "><U><font style='white-space: pre-wrap;'>http://www.sec.gov/Archives/edgar/data/9631/000119312524253771/d875135d424b3.htm</font></U></FONT></A></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>These documents (together, the &#8220;Note Prospectus&#8221;) have been filed as part of a registration statement with the SEC, which may, without cost, be accessed on the SEC website as indicated above or obtained from Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated (&#8220;MLPF&amp;S&#8221;) or BofAS by calling 1-800-294-1322. You should read the Note Prospectus, including this term sheet, for information about us and this offering. Any prior or contemporaneous oral statements and any other written materials you may have received are superseded by the Note Prospectus. Capitalized terms used but not defined in this term sheet have the meanings set forth in product supplement EQUITY STR-1. Unless otherwise indicated or unless the context requires otherwise, all references in this document to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or similar references are to BNS.</font></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Investor Considerations</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="55.04%" style="width: 55.04%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="54.96%" style="width: 54.96%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You may wish to consider an investment in the notes if:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes may not be an appropriate investment for you if:</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You anticipate that the Closing Market Price of the Market Measure on any of the Observation Dates will be equal to or greater than the Call Level and, if the notes are automatically called prior to the final Observation Date, you accept an early exit from your investment.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You accept that the return on the notes will be limited to the return represented by the applicable Call Premium even if the percentage change in the price of the Market Measure is greater than the applicable Call Premium.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You are willing to risk a loss of principal and return if the notes are not automatically called and the Closing Market Price of the Underlying Fund decreases from the Starting Value to an Ending Value that is less than the Threshold Value.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You are willing to forgo interest payments that are paid on conventional interest-bearing debt securities.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You are willing to forgo the benefits of directly owning the Underlying Fund or the securities held by the Underlying Fund, including dividends and other distributions.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You are willing to accept a limited or no market for sales prior to maturity, and understand that the market prices for the notes, if any, will be affected by various factors, including our actual and perceived creditworthiness, our internal funding rate and fees and charges on the notes.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You are willing to assume our credit risk, as issuer of the notes, for all payments under the notes, including the Call Amount or the Redemption Amount.</font></FONT></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You wish to make an investment that cannot be automatically called.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You believe that the Closing Market Price of the Underlying Fund will decrease from the Starting Value to an Ending Value that is below the Threshold Value.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You anticipate that the Observation Level will be less than the Call Level on each Observation Date.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You seek an uncapped return on your investment.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You seek 100% principal repayment or preservation of capital.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You seek interest payments or other current income on your investment.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You want to receive the benefits of directly owning the Underlying Fund or the securities held by the Underlying Fund, including dividends and other distributions.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You seek an investment for which there will be a liquid secondary market.</font></FONT></FONT></P>
                            <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B8F22; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You are unwilling or are unable to take market risk on the notes or to take our credit risk as issuer of the notes.</font></FONT></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We urge you to consult your investment, legal, tax, accounting, and other advisors concerning an investment in the notes.</font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>4</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 5.5pt; margin-bottom: 0; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Examples of Hypothetical Payments</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The following examples are for purposes of illustration only. They are based on </font></FONT><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>hypothetical</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> values and show </font></FONT><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>hypothetical</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> returns on the notes. They illustrate the calculation of the Call Amount or Redemption Amount, as applicable, based on the hypothetical terms set forth below. </font></FONT><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The actual amount you receive and the resulting return will depend on the actual Starting Value, Threshold Value, Call Level, Observation Levels, and term of your investment.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The following examples do not take into account any tax consequences from investing in the notes. These examples are based on:</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 1.5pt; margin-left: 29.70pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-family: Arial, sans-serif; color: black; font-size: 9.0pt; ">(1)</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>a Starting Value of 100.00;</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; margin-left: 29.70pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-family: Arial, sans-serif; color: black; font-size: 9.0pt; ">(2)</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>a Threshold Value of 85.00;</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; margin-left: 29.70pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-family: Arial, sans-serif; color: black; font-size: 9.0pt; ">(3)</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>a Call Level of 100.00; </font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; margin-left: 29.70pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-family: Arial, sans-serif; color: black; font-size: 9.0pt; ">(4)</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>an expected term of the notes of approximately five years, if the notes are not called on any of the first four Observation Dates;</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; margin-left: 29.70pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-family: Arial, sans-serif; color: black; font-size: 9.0pt; ">(5)</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>a Call Premium of 14.61% of the principal amount if the notes are called on the first Observation Date, 29.22% if called on the second Observation Date, 43.83% if called on the third Observation Date, 58.44% if called on the fourth Observation Date and 73.05% if called on the final Observation Date ; and</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 1.5pt; margin-bottom: 0; margin-left: 29.70pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-family: Arial, sans-serif; color: black; font-size: 9.0pt; ">(6)</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Observation Dates occurring approximately one, two, three, four and five years after the pricing date.</font></FONT></FONT></P>
                <P style="margin-top: 5.5pt; margin-bottom: 6.6pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The </font></FONT><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>hypothetical</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> Starting Value of 100.00 used in these examples has been chosen for illustrative purposes only. The actual Starting Value of the Underlying Fund is $49.00, which was the Closing Market Price of the Underlying Fund on the pricing date.</font></FONT></P>
                <P style="margin-top: 5.5pt; margin-bottom: 6.6pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>For recent actual prices of the Underlying Fund, see &#8220;The Underlying Fund&#8221; section below. The price of the Underlying Fund will not include any income generated by dividends paid on the Underlying Fund or the securities held by the Underlying Fund, which you would otherwise be entitled to receive if you invested in those stocks directly. In addition, all payments on the notes are subject to issuer credit risk.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-style: italic; text-decoration-style: solid; text-decoration-line: underline; font-family: Arial, sans-serif; font-size: 9.0pt; "><U><font style='white-space: pre-wrap;'>Notes Are Called on an Observation Date</font></U></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes will be called at $10.00 plus the applicable Call Premium if the Observation Level on one of the Observation Dates is equal to or greater than the Call Level. </font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Example 1</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> - The Observation Level on the first Observation Date is 150.00. Therefore, the notes will be called at $10.00 plus the Call Premium of $1.461 = $11.461 per unit. </font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Example 2</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> - The Observation Level on the first Observation Date is below the Call Level, but the Observation Level on the second Observation Date is 120.00. Therefore, the notes will be called at $10.00 plus the Call Premium of $2.922 = $12.922 per unit.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Example 3</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> - The Observation Levels on the first two Observation Dates are below the Call Level, but the Observation Level on the third Observation Date is 130.00. Therefore, the notes will be called at $10.00 plus the Call Premium of $4.383 = $14.383 per unit.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Example 4</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> - The Observation Levels on the first three Observation Dates are below the Call Level, but the Observation Level on the fourth Observation Date is 135.00. Therefore, the notes will be called at $10.00 plus the Call Premium of $5.844 = $15.844 per unit.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Example 5</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> - The Observation Levels on the first four Observation Dates are below the Call Level, but the Observation Level on the fifth and final Observation Date is 145.00. Therefore, the notes will be called at $10.00 plus the Call Premium of $7.305 = $17.305 per unit.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-style: italic; text-decoration-style: solid; text-decoration-line: underline; font-family: Arial, sans-serif; font-size: 9.0pt; "><U><font style='white-space: pre-wrap;'>Notes Are Not Called on Any Observation Date</font></U></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Example 6</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> - The notes are not called on any Observation Date and the Ending Value is equal to or greater than the Threshold Value. The Redemption Amount will be equal to the principal amount. For example, if the Ending Value is 85.00, the Redemption Amount per unit will be $10.00.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Example 7</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> - The notes are not called on any Observation Date and the Ending Value is less than the Threshold Value. The Redemption Amount will be less, and possibly significantly less, than the principal amount. For example, if the Ending Value is 70.00, the Redemption Amount per unit will be:</font></FONT></P>
                <P style="text-align: center; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'><IMG SRC="image_007.jpg" ALT="" STYLE="height: 52px; width: 225px"></font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>5</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Summary of the Hypothetical Examples</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: auto; width: 100.00%; table-layout: fixed; border-collapse: collapse; margin-right: auto; ">
                    <TR>
                        <TD width="25.96%" style="width: 25.96%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="11.11%" style="width: 11.11%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="12.36%" style="width: 12.36%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="12.36%" style="width: 12.36%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="11.13%" style="width: 11.13%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="11.11%" style="width: 11.11%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="0.02%" style="width: 0.02%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="12.36%" style="width: 12.36%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="13.57%" style="width: 13.57%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="0.02%" style="width: 0.02%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
                        </TD>
                        <TD colspan="5" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Notes Are Called on an Observation Date</font></FONT></P>
                        </TD>
                        <TD colspan="3" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Notes Are Not Called on Any Observation Date</font></FONT></P>
                        </TD>
                        <TD>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Example 1</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Example 2</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Example 3</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Example 4</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Example 5</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Example 6</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Example 7</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Starting Value</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Call Level</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Threshold Value</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>85.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>85.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>85.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>85.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>85.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>85.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>85.00</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Observation Level on the First Observation Date</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>150.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>90.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>90.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>90.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>90.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>88.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>88.00</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Observation Level on the Second Observation Date</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>N/A</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>120.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>90.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>90.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>90.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>78.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>78.00</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Observation Level on the Third Observation Date</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>N/A</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>N/A</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>130.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>90.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>90.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>85.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>85.00</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Observation Level on the Fourth Observation Date</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>N/A</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>N/A</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>N/A</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>135.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>90.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>95.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>95.00</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Observation Level on the Final Observation Date</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>N/A</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>N/A</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>N/A</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>N/A</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>145.00</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>85.00</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>70.00</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Return on the Underlying Fund</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>50.00%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>20.00%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>30.00%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>35.00%</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>45.00%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>-15.00%</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>-30.00%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Return on the Notes</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>14.61%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>29.22%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>43.83%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>58.44%</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>73.05%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>0.00%</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>-15.00%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 17.32pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Call Amount / Redemption Amount per Unit</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$11.461</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$12.922</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$14.383</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$15.844</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$17.305</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$10.000</font></FONT></P>
                        </TD>
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 0.0pt; padding-right: 0.0pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.65pt; margin-bottom: 1.65pt; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>$8.500</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>6</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Risk Factors</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>There are important differences between the notes and a conventional debt security. An investment in the notes involves significant risks, including those listed below. You should carefully review the more detailed explanation of risks relating to the notes in the &#8220;Risk Factors&#8221; sections beginning on page PS-7 of product supplement EQUITY STR-1, page S-2 of the prospectus supplement, and page 8 of the prospectus identified above. We also urge you to consult your investment, legal, tax, accounting, and other advisors concerning an investment in the notes.</font></FONT></P>
                <P style="margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; text-decoration-style: solid; text-decoration-line: underline; font-size: 9.0pt; "><U><font style='white-space: pre-wrap;'>Structure</font></U><U><font style='white-space: pre-wrap;'>-</font></U><U><font style='white-space: pre-wrap;'>Related Risks </font></U></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>If the notes are not automatically called, depending on the performance of the Underlying Fund as measured shortly before the maturity date, your investment may result in a loss; there is no guaranteed return of principal.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Your return on the notes may be less than the yield you could earn by owning a conventional fixed or floating rate debt security of comparable maturity.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Your investment return is limited to the return represented by the applicable Call Premium and may be less than a comparable investment directly in the Underlying Fund or the securities held by the Underlying Fund.</font></FONT></FONT></P>
                <P style="text-indent: -19.8pt; padding-left: 19.8pt; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; text-decoration-style: solid; text-decoration-line: underline; font-size: 9.0pt; "><U><font style='white-space: pre-wrap;'>Market Measure</font></U><U><font style='white-space: pre-wrap;'>-</font></U><U><font style='white-space: pre-wrap;'>Related Risks</font></U></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The sponsor of the Underlying Fund may adjust the Underlying Fund in a way that may adversely affect the value of the notes and the amount payable on the notes, and these entities have no obligation to consider your interests.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The sponsor of the Solactive Global Uranium &amp; Nuclear Components Total Return Index (the &#8220;Underlying Index&#8221;), described below, may adjust the Underlying Index in a way that affects its level, and has no obligation to consider your interests.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You will have no rights of a holder of the Underlying Fund or the securities held by the Underlying Fund, and you will not be entitled to receive any shares of the Underlying Fund or the securities held by the Underlying Fund, or any dividends or other distributions in respect of the Underlying Fund or the securities held by the Underlying Fund.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>While we, MLPF&amp;S, BofAS or their or our respective affiliates may from time to time own shares of the Underlying Fund or the securities held by the Underlying Fund, none of us, MLPF&amp;S, BofAS or our or their respective affiliates control the Underlying Fund or any company held by the Underlying Fund, and have not verified any disclosure made by the Underlying Fund or any other company.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>There are liquidity and management risks associated with the Underlying Fund.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The performance of the Underlying Fund may not correlate with the performance of its Underlying Index as well as the net asset value per share of the Underlying Fund, especially during periods of market volatility when the liquidity and the market price of the shares of the Underlying Fund and/or the securities held by the Underlying Fund may be adversely affected, sometimes materially.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Redemption Amount will not be adjusted for all corporate events that could affect the Underlying Fund. See &#8220;Description of the Notes&#8212;Anti-Dilution and Discontinuance Adjustments Relating to Underlying Funds&#8221; beginning on page PS-29 of product supplement EQUITY STR-1.</font></FONT></FONT></P>
                <P style="text-indent: -19.8pt; padding-left: 19.8pt; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; text-decoration-style: solid; text-decoration-line: underline; font-size: 9.0pt; "><U><font style='white-space: pre-wrap;'>Valu</font></U><U><font style='white-space: pre-wrap;'>ation</font></U><U><font style='white-space: pre-wrap;'>-</font></U><U><font style='white-space: pre-wrap;'> and Market</font></U><U><font style='white-space: pre-wrap;'>-</font></U><U><font style='white-space: pre-wrap;'>Related Risks</font></U></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #76923C; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Our initial estimated value of the notes is lower than the public offering price of the notes. Our initial estimated value of the notes is only an estimate. The public offering price of the notes exceeds our initial estimated value because it includes costs associated with selling and structuring the notes, as well as hedging our obligations under the notes with a third party, which may include BofAS or one of its affiliates. These costs include the underwriting discount and an expected hedging related charge, as further described in &#8220;Structuring the Notes&#8221; on page TS-15.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #76923C; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Our initial estimated value of the notes does not represent future values of the notes and may differ from others&#8217; estimates. Our initial estimated value of the notes is determined by reference to our internal pricing models when the terms of the notes are set. These pricing models consider certain factors, such as our internal funding rate on the pricing date, the expected term of the notes, market conditions and other relevant factors existing at that time, and our assumptions about market parameters, which can include volatility, dividend rates, interest rates and other factors. Different pricing models and assumptions could provide valuations for the notes that are different from our initial estimated value. In addition, market conditions and other relevant factors in the future may change, and any of our assumptions may prove to be incorrect. On future dates, the market value of the notes could change significantly based on, among other things, the performance of the Underlying Fund, changes in market conditions, our creditworthiness, interest rate movements and other relevant factors. These factors, together with various credit, market and economic factors over the term of the notes, are expected to reduce the price at which you may be able to sell the notes in any secondary market and will affect the value of the notes in complex and unpredictable ways. Our initial estimated value does not represent a minimum price at which we or any agents would be willing to buy your notes in any secondary market (if any exists) at any time.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #76923C; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Our initial estimated value is not determined by reference to credit spreads or the borrowing rate we would pay for our conventional fixed-rate debt securities. The internal funding rate used in the determination of our initial estimated value of the notes generally represents a discount from the credit spreads for our conventional fixed-rate debt securities and the borrowing </font></FONT></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>7</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.60pt; "><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>rate we would pay for our conventional fixed-rate debt securities. If we were to use the interest rate implied by the credit spreads for our conventional fixed-rate debt securities, or the borrowing rate we would pay for our conventional fixed-rate debt securities, we would expect the economic terms of the notes to be more favorable to you. Consequently, our use of an internal funding rate for the notes would have an adverse effect on the economic terms of the notes, the initial estimated value of the notes on the pricing date, and the price at which you may be able to sell the notes in any secondary market.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>A trading market is not expected to develop for the notes. None of us, MLPF&amp;S or BofAS is obligated to make a market for, or to repurchase, the notes. There is no assurance that any party will be willing to purchase your notes at any price in any secondary market.</font></FONT></FONT></P>
                <P style="text-indent: -19.8pt; padding-left: 19.8pt; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; text-decoration-style: solid; text-decoration-line: underline; font-size: 9.0pt; "><U><font style='white-space: pre-wrap;'>Conflict</font></U><U><font style='white-space: pre-wrap;'>-</font></U><U><font style='white-space: pre-wrap;'>Related Risks</font></U></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Our business, hedging and trading activities, and those of MLPF&amp;S, BofAS and our and their respective affiliates (including trades in the Underlying Fund or the securities held by the Underlying Fund), and any hedging and trading activities we, MLPF&amp;S, BofAS or our or their respective affiliates engage in for our clients&#8217; accounts, may affect the market value of, and return on, the notes and may create conflicts of interest with you.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>There may be potential conflicts of interest involving the calculation agent, which is BofAS. We have the right to appoint and remove the calculation agent.</font></FONT></FONT></P>
                <P style="text-indent: -19.8pt; padding-left: 19.8pt; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; text-decoration-style: solid; text-decoration-line: underline; font-size: 9.0pt; "><U><font style='white-space: pre-wrap;'>General Credit</font></U><U><font style='white-space: pre-wrap;'>-</font></U><U><font style='white-space: pre-wrap;'>Related</font></U><U><font style='white-space: pre-wrap;'> Risks</font></U></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Payments on the notes are subject to our credit risk, and actual or perceived changes in our creditworthiness are expected to affect the value of the notes. If we become insolvent or are unable to pay our obligations, you may lose your entire investment.</font></FONT></FONT></P>
                <P style="text-indent: -19.8pt; padding-left: 19.8pt; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; text-decoration-style: solid; text-decoration-line: underline; font-size: 9.0pt; "><U><font style='white-space: pre-wrap;'>Tax</font></U><U><font style='white-space: pre-wrap;'>-</font></U><U><font style='white-space: pre-wrap;'>Related Risks</font></U></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The U.S. federal income tax consequences of the notes are uncertain, and may be adverse to a holder of the notes. See &#8220;Summary of U.S. Federal Income Tax Consequences&#8221; below.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; margin-left: 39.00pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: #5B862B; font-size: 9.0pt; ">&#65517;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The conclusion that no portion of the interest paid or credited or deemed to be paid or credited on a note will be &#8220;Participating Debt Interest&#8221; subject to Canadian withholding tax is based in part on the current published administrative position of the CRA. There cannot be any assurance that CRA&#8217;s current published administrative practice will not be subject to change, including potential expansion in the current administrative interpretation of Participating Debt Interest subject to Canadian withholding tax. If, at any time, the interest paid or credited or deemed to be paid or credited on a note is subject to Canadian withholding tax, you will receive an amount that is less than the Redemption Amount. You should consult your own adviser as to the potential for such withholding and the potential for reduction or refund of part or all of such withholding, including under any bilateral Canadian tax treaty the benefits of which you may be entitled. For a discussion of the Canadian federal income tax consequences of investing in the notes, see &#8220;Summary of Canadian Federal Income Tax Consequences&#8221; below, &#8220;Canadian Taxation&#8212;Debt Securities&#8221; on page 66 of the prospectus and &#8220;Supplemental Discussion of Canadian Federal Income Tax Consequences&#8221; on page PS-39 of product supplement EQUITY STR-1.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Additional Risk Factors</font></FONT></P>
                <P style="margin-top: 5.5pt; text-indent: -19.8pt; padding-left: 19.8pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The securities held by the Underlying Fund are concentrated in the uranium sector.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>All or substantially all of the securities held by the Underlying Fund are issued by companies whose primary line of business is directly associated with the uranium mining, exploration and technologies related to the uranium industry. As a result, the value of the notes may be subject to greater volatility and may be more adversely affected by a single economic, political or regulatory occurrence affecting this sector than a different investment linked to securities of a more broadly diversified group of issuers. The uranium sector is exposed to risks related to the uranium mining industry, the exploration industry, the oil, gas and consumable fuels industry and the energy sector. The uranium mining industry can be significantly affected by competitive pressures in the uranium mining industry and the price of uranium. The exploration and development of mineral deposits involve significant financial risks over a significant period of time. Few properties that are explored are ultimately developed into producing mines. Major expenditures may be required to establish reserves by drilling and to construct mining and processing facilities at a site. In addition, mineral exploration companies typically operate at a loss and are dependent on securing equity and/or debt financing, which might be more difficult to secure for an exploration company than for a more established counterpart. Companies in this sector are subject to substantial government regulation and contractual fixed pricing, which may increase the cost of business and limit these companies&#8217; earnings.</font></FONT></P>
                <P style="margin-top: 5.5pt; text-indent: -19.8pt; padding-left: 19.8pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes are subject to foreign currency exchange rate risk.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Underlying Fund holds securities traded outside of the United States. The Underlying Fund&#8217;s share price will fluctuate based upon its net asset value, which will in turn depend in part upon changes in the value of the currencies in which the securities held by the Underlying Fund are traded. Accordingly, investors in the notes will be exposed to currency exchange rate risk with respect to each of the currencies in which the securities held by the Underlying Fund are traded. An investor&#8217;s net exposure will depend on the extent to which these currencies strengthen or weaken against the U.S. dollar. If the dollar strengthens against these currencies, the net asset value of the Underlying Fund will be adversely affected and the price of the Underlying Fund may decrease.</font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>8</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 5.5pt; text-indent: -19.8pt; padding-left: 19.8pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes are subject to risks associated with emerging markets.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Some of the equity securities composing the Underlying Fund have been issued by companies in countries based in emerging markets. Emerging markets pose further risks in addition to the risks associated with investing in foreign equity markets generally. Countries with emerging markets may have relatively unstable financial markets and governments; may present the risks of nationalization of businesses; may impose restrictions on currency conversion, exports or foreign ownership and prohibitions on the repatriation of assets; may pose a greater likelihood of regulation by the national, provincial and local governments of the emerging market countries, including the imposition of currency exchange laws and taxes; and may have less protection of property rights, less access to legal recourse and less comprehensive financial reporting and auditing requirements than more developed countries. The economies of countries with emerging markets may be based on only a few industries, may be highly vulnerable to changes in local or global trade conditions, and may suffer from extreme and volatile debt burdens or inflation rates. Local securities markets may trade a small number of securities and may be unable to respond effectively to increases in trading volume, potentially making prompt liquidation of holdings difficult or impossible at times. Moreover, the economies in such countries may differ unfavorably from the economy in the United States in such respects as growth of gross national product, rate of inflation, capital reinvestment, resources, self-sufficiency and balance of payment positions. The currencies of emerging markets may also be less liquid and more volatile than those of developed markets and may be affected by political and economic developments in different ways than developed markets. The foregoing factors may adversely affect the performance of companies based in emerging markets. </font></FONT></P>
                <P style="margin-top: 5.5pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>A limited number of securities held by the Underlying Fund may affect its price, and the securities held by the Underlying Fund are not necessarily representative of the uranium industry.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>While the securities held by the Underlying Fund are common stocks of companies generally considered to be involved in various segments of the uranium industry, the securities held by the Underlying Fund may not follow the price movements of the entire uranium industry generally. As of the date of this term sheet, a small number of securities make up a significant portion of the total weight of the Underlying Fund&#8217;s holdings. If these securities decline in value, the Underlying Fund will likely decline in value even if security prices in the uranium industry generally increase in value.</font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>9</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>The Underlying Fund</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>All disclosures contained in this term sheet regarding the Underlying Fund, including, without limitation, its make-up, method of calculation, and changes in its components, have been derived from publicly available sources, without independent verification. The information reflects the policies of, and is subject to change by, Global X Management Company LLC, the advisor to the Underlying Fund (the &#8220;sponsor&#8221; or &#8220;Global X&#8221;). The sponsor has no obligation to continue to publish, and may discontinue publication of, the Underlying Fund. The consequences of the sponsor discontinuing publication of the Underlying Fund are discussed in the section entitled &#8220;Description of the Notes &#8212;Anti-Dilution and Discontinuance Adjustments Relating to Underlying Funds&#8221; beginning on page PS-29 of product supplement EQUITY STR-1. None of us, the calculation agent, MLPF&amp;S, BofAS or our or their respective affiliates accepts any responsibility for the calculation, maintenance or publication of the Underlying Fund or any successor Underlying Fund.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; text-decoration-style: solid; text-decoration-line: underline; font-size: 9.0pt; "><U><font style='white-space: pre-wrap;'>The </font></U><U><font style='white-space: pre-wrap;'>Global X Uranium ETF</font></U></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> The shares of the Underlying Fund are issued by Global X Funds</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>, a registered investment company. The Underlying Fund seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Underlying Index, a modified market capitalization-weighted index that is designed to measure the performance of global companies that have or are expected to have business operations or exposure in the uranium industry, including uranium mining, exploration for uranium, uranium investments, technologies related to the uranium industry and the production of nuclear components. Information provided to or filed with the SEC under the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended, can be located by reference to SEC file numbers 333-151713 and 811-22209 and can be inspected through the SEC&#8217;s website at www.sec.gov. The Underlying Fund is listed on NYSE Arca, Inc. under the ticker symbol &#8220;URA.&#8221; For more information about the Underlying Index, see &#8220;&#8212;The Solactive Global Uranium &amp; Nuclear Components Total Return Index&#8221; below.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Solactive Global Uranium &amp; Nuclear Components Total Return Index</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We obtained all information contained in this term sheet regarding the Underlying Index including, without limitation, its make-up, method of calculation and changes in its components, from publicly available information. That information reflects the policies of, and is subject to change by, Solactive AG (&#8220;Solactive&#8221;), the index sponsor. Solactive has no obligation to continue to publish, and may discontinue publication of, the Underlying Index at any time. Neither we nor any agent has independently verified the accuracy or completeness of any information with respect to the Underlying Index in connection with the offer and sale of notes.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Underlying Index is calculated on each weekday on which the New York Stock Exchange (&#8220;NYSE&#8221;), The Nasdaq Stock Market and the London Stock Exchange are each open for general business (each, a &#8220;Calculation Day&#8221;). The Underlying Index is reported by Bloomberg L.P. under the ticker symbol &#8220;SOLURANT.&#8221; </font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Underlying Index is a modified market capitalization-weighted index that is designed to measure the performance of global companies that have or are expected to have business operations or exposure in the uranium industry including uranium mining, exploration for uranium, uranium investments, technologies related to the uranium industry and the production of nuclear components. The Underlying Index has a base date of January 30, 2018.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Composition of the Solactive Global Uranium &amp; Nuclear Components Total Return Index</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Selection of Index Components</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The composition of the Underlying Index is adjusted twice a year on the last day of each January and July on which the New York Stock Exchange is open for trading (a &#8220;NYSE trading day&#8221;), </font></FONT><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>provided</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> that if that day is not a day on which the New York Stock Exchange, the Nasdaq and the London Stock Exchange are open for general business (a &#8220;Calculation Day), then the relevant adjustment will take place on the second following Calculation Day. On the tenth NYSE trading day before an Adjustment Day (a &#8220;Selection Day&#8221;), Solactive provides the &#8220;Selection Pool&#8221; which, in respect of a Selection Day, consists of the companies that fulfil the following conditions:</font></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Primary listing in one of the countries that are part of the Developed Markets and Emerging Markets (excluding China, India and Taiwan) as defined by the Solactive Country Classification;</font></FONT></FONT></P>
                <P style="margin-top: 1.5pt; margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Companies with significant business operations in the uranium industry (particularly in uranium mining and exploration for uranium) (&#8220;Pure Play Companies&#8221;) or conducting business operations that are related to the uranium industry (particularly in uranium mining, exploration for uranium, physical uranium investments and technologies related to the uranium industry) in which they generate large absolute revenues (&#8220;Non-Pure Play Companies&#8221;), or companies in the list of &#8220;Nuclear Component Producers&#8221; prepared by Solactive (&#8220;Nuclear Component Producer Companies&#8221;);</font></FONT></FONT></P>
                <P style="margin-top: 1.5pt; margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Free float market capitalization of at least US$50 million for companies that are not currently included in the Underlying Index on the Selection Day or at least US$30 million for companies that are currently included in the Underlying Index (the &#8220;Index Components&#8221;) on the Selection Day;</font></FONT></FONT></P>
                <P style="margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-top: 1.5pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Average daily trading value in the three months prior to the Selection Day (or, in the case of a company that has completed a significant initial public offering (&#8220;significant IPO&#8221;) less than three months prior to the Selection Day, i.e. an IPO with a company level total market capitalization greater than the company level total market capitalization of at least 50% of the current Index Components as of the previous Selection Day, the period from the security&#8217;s first trading day to the Selection Day) of at least US$100,000 for companies that are not currently included in the Underlying Index on the Selection Day or at least US$50,000 for companies that are currently included in the Underlying Index on the Selection Day; and</font></FONT></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>10</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-bottom: 11.0pt; line-height: 1.35; text-align: justify; margin-top: 1.5pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Initial public offerings with less than three calendar months of trading history as of the Selection Day must have been listed at least 10 calendar days prior to the Selection Day, if considered as significant IPO, and three calendar months prior to the Selection Day, in the case of other IPOs.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The companies selected after completion of the above steps will be considered as exposed to controversial weapons and removed from the Selection Pool if (1) it is involved in the production development or maintenance of anti-personnel mines, biological or chemical weapons, cluster munitions, depleted uranium, nuclear weapons or any other weapons that violate humanitarian principles through normal use; (2) it produces or develops key and dedicated components for controversial weapons; (3) it holds more than a 20% stake in a company that is involved in controversial weapons; or (4) it is more than 50% owned by a company that is involved in controversial weapons.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The overall number of Non-Pure Play Companies and Nuclear Component Producer Companies (in aggregate) will be capped at 15, with preference given to current Index Components first and then prioritized by free float market capitalization. Otherwise, all members of the Selection Pool are included as Index Components. The selection of the Index Components is fully rule-based and no discretionary decisions can be made.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Weighting of the Index Components</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>On each Selection Day, the weights of the selected Index Components are determined by applying an effective market capitalization weighting scheme that accounts for liquidity in determining final weights.</font></FONT></P>
                <P style="margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-top: 0; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The weight of a selected Index Component will be determined based on the lesser of free float market capitalization and average daily trading volume multiplied by 2000.</font></FONT></FONT></P>
                <P style="margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-top: 1.5pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Non-Pure Play Companies and Nuclear Component Producer Companies will be capped at 2.00%.</font></FONT></FONT></P>
                <P style="margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-top: 1.5pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The maximum weight of a Pure Play Company is 22.50%.</font></FONT></FONT></P>
                <P style="margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-top: 1.5pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The aggregate weight of all Pure Play Companies with a weight larger than or equal to 5.00% will be capped at 47.50%.</font></FONT></FONT></P>
                <P style="margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-top: 1.5pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>All remaining Pure Play Companies are capped at 4.75%.</font></FONT></FONT></P>
                <P style="margin-top: 1.5pt; margin-bottom: 11.0pt; line-height: 1.35; text-align: justify; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The aggregate weight of all Index Components structured as investment trusts which provide exposure to physical uranium is capped at 10%. Any excess weight resulting from this procedure will be redistributed to all the remaining constituents which are not capped on a pro-rata basis.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Quarterly Diversification Review</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>On each Monitoring Selection Day (as defined below), the Index Components will be reviewed for a breach of the following criteria:</font></FONT></P>
                <P style="margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-top: 0; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The maximum weight of the top Index Component must not be larger than 25%. If this criterion is breached, the stock is capped at 22% and the excess weight is redistributed to other non-capped stocks.</font></FONT></FONT></P>
                <P style="margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-top: 1.5pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The maximum aggregate weight of the top 5 Index Components must not exceed 60%. If this criterion is breached, the stocks will be proportionally capped at 55% and the excess weight is redistributed to other non-capped stocks.</font></FONT></FONT></P>
                <P style="margin-bottom: 1.5pt; line-height: 1.35; text-align: justify; margin-top: 1.5pt; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The maximum weight of Index Components with a market liquidity below 250,000 shares traded (monthly average of the previous 6 months or available history if shorter) and US$25 million monthly average daily traded value (monthly average of the previous 6 months or available history if shorter) must not exceed 30%. If this criterion is breached, the stocks with a market liquidity below 250,000 shares traded (monthly average of the previous 6 months or available history if shorter) and US$25 million monthly average daily traded value (monthly average of the previous 6 months or available history if shorter) will be proportionally capped at 25% and the excess weight is redistributed to other non-capped stocks.</font></FONT></FONT></P>
                <P style="margin-top: 1.5pt; margin-bottom: 11.0pt; line-height: 1.35; text-align: justify; margin-left: 39.60pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 9.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The maximum weight of Index Components with a market capitalization below US$100 million must not account for more than 10%. If this criterion is breached, stocks with market capitalization below US$100 million will be proportionally capped at 9% and the excess weight is redistributed to other non-capped stocks.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>This reweighting process will be repeated until none of the constraints are breached. In the event that the above criteria cannot be satisfied using the buffers described above, the weighting will be reviewed by an oversight committee composed of staff from Solactive and its subsidiaries (the &#8220;Oversight Committee&#8221;). After the review, the decision will be announced publicly.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The &#8220;Monitoring Selection Day&#8221; is the NYSE trading day that is ten NYSE trading days before the Monitoring Adjustment Day. The &#8220;Monitoring Adjustment Day&#8221; is the last NYSE trading day in each April and October, provided that if that day is not a Calculation Day, then the relevant Monitoring Adjustment Day will be the second following Calculation Day.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Rebalance</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>In order to reflect the new selection of the Index Components determined on the Selection Day and new weights as determined on the Monitoring Selection Day, the Underlying Index is adjusted on the Adjustment Day and Monitoring Adjustment Day (each, a &#8220;Rebalance Day&#8221;) after the calculation time of its closing value. This is carried out by implementing the shares as determined on the Selection Day based on the weights calculated on the Selection Day. Solactive will publish any changes made to the Index Components with sufficient notice before the Rebalance Day on the Solactive website. The Underlying Index is not rebalanced extraordinarily.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Calculation of the Solactive Global Uranium &amp; Nuclear Components Total Return Index</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Underlying Index is calculated as a net total return index. A net total return index seeks to replicate the overall return from holding a portfolio consisting of the Index Components. In order to achieve this aim, a net total return index considers payments, such as dividends, </font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>11</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>after the deduction of any withholding tax or other amounts an investor holding the Index Components would typically be exposed to.The Underlying Index&#8217;s index level on a given Calculation Day is calculated as the sum of the market capitalization of the Index Components divided by the divisor, which is a mathematical factor defined at the inception of the Underlying Index. The divisor is adjusted by certain corporate actions and index rebalances. Additionally, dividends paid by any Index Component are applied across the entire basket by changing the divisor. The level of the Underlying Index changes based on the change of the prices of its Index Components taking into account their weight in the Underlying Index and any currency conversion in case the price of an Index Component is not quoted in U.S. dollars.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>For intraday calculation of the Underlying Index, prices of Index Components not in U.S. dollars are converted using the current Intercontinental Exchange spot foreign exchange rate. If there is no current price available for an Index Component, the later of the most recent closing price or the last available trading price for the preceding trading day is used in the calculation. For the daily index closing value calculation, trading prices of Index Components not in U.S. dollars are converted using the 4pm London time WM Fixing quoted by Reuters. If there is no 4pm London time WM Fixing for the relevant Calculation Day, the last available 4pm London time WM Fixing will be used for the index closing value calculation.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Under certain circumstances, an adjustment of the Underlying Index may be necessary between two regular Rebalance Days. Such adjustment has to be made if a corporate action in relation of an Index Component occurs. Such adjustment may have to be done in relation to an Index Component and/or may also affect the number of Index Components and/or the weighting of certain Index Components.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Maintenance of the Solactive Global Uranium &amp; Nuclear Components Total Return Index</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The composition of the Underlying Index is reviewed on each Selection Day. Solactive will publish any changes made to the Index Components with sufficient notice before the relevant Adjustment Day.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>As part of the index maintenance, Solactive will consider various events&#8212;also referred to as corporate actions&#8212;which result in an adjustment to the Underlying Index between two regular rebalances. Such events have a material impact on the price, weighting or overall integrity of Index Components. Therefore, they need to be accounted for in the calculation of the Underlying Index. Corporate actions will be implemented from the cum-day to the ex-day of the corporate action, so that the adjustment to the Undelrying Index coincides with the occurrence of the price effect of the respective corporate action. Solactive considers the following, but not conclusive, list of corporate action as relevant for index maintenance: cash distributions, stock distributions, share splits, reverse splits, capital increases, share repurchases, spin-offs, mergers and acquisitions, delistings, nationalization of a company and insolvency.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Oversight of the Solactive Global Uranium &amp; Nuclear Components Total Return Index</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Oversight Committee is responsible for decisions regarding any amendments to the rules of the Underlying Index. Any amendment to these rules must be submitted to the Oversight Committee for prior approval and will be made in compliance with Solactive&#8217;s methodology policy.</font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>12</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Historical Data</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The following graph shows the daily historical performance of the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-weight: bold; font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>in the period from January 1, 2015 through December 11, 2025. We obtained this historical data from Bloomberg L.P. We have not independently verified the accuracy or completeness of the information obtained from Bloomberg L.P. On the pricing date, the Closing Market Price of the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-weight: bold; font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>was $49.00. The graph below may have been adjusted to reflect certain corporate actions such as stock splits and reverse stock splits.</font></FONT></P>
                <P style="text-align: center; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Historical Performance of the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></P>
                <P style="text-align: center; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; ">                        <IMG width="467.78pt" height="315.98pt" src="image5.jpg" style="width: 467.78pt; height: 315.98pt; ">
                        </FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>This historical data on the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-weight: bold; font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>is not necessarily indicative of the future performance of the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-weight: bold; font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>or what the value of the notes may be. Any historical upward or downward trend in the price per share of the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-weight: bold; font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>during any period set forth above is not an indication that the price per share of the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-weight: bold; font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>is more or less likely to increase or decrease at any time over the term of the notes.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You should consult publicly available sources for the prices and trading patterns of the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>.</font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>13</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Supplement to the Plan of Distribution</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Under our distribution agreement with BofAS, BofAS will purchase the notes from us as principal at the public offering price indicated on the cover of this term sheet, less the indicated underwriting discount.</font></FONT></P>
                <P style="margin-top: 5.5pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>MLPF&amp;S will purchase the notes from BofAS for resale, and will receive a selling concession in connection with the sale of the notes in an amount up to the full amount of the underwriting discount set forth on the cover of this term sheet.</font></FONT></P>
                <P style="margin-top: 5.5pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We will pay a fee to LFT Securities, LLC for providing certain electronic platform services with respect to this offering, which will reduce the economic terms of the notes to you. An affiliate of BofAS has an ownership interest in LFT Securities, LLC.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We will deliver the notes against payment therefor in New York, New York on a date that is greater than one business day following the pricing date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes more than one business day prior to the settlement date will be required to specify alternative settlement arrangements to prevent a failed settlement.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes will not be listed on any securities exchange. In the original offering of the notes, the notes will be sold in minimum investment amounts of 100 units. If you place an order to purchase the notes, you are consenting to MLPF&amp;S and/or one of its affiliates acting as a principal in effecting the transaction for your account.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>MLPF&amp;S and BofAS may repurchase and resell the notes, with repurchases and resales being made at prices related to then-prevailing market prices or at negotiated prices, and these prices will include MLPF&amp;S&#8217;s and BofAS&#8217;s trading commissions and mark-ups or mark-downs. MLPF&amp;S and BofAS may act as principal or agent in these market-making transactions; however, neither is obligated to engage in any such transactions. At their discretion, for a short, undetermined initial period after the issuance of the notes, MLPF&amp;S and BofAS may offer to buy the notes in the secondary market at a price that may exceed the initial estimated value of the notes. Any price offered by MLPF&amp;S or BofAS for the notes will be based on then-prevailing market conditions and other considerations, including the performance of the Underlying Fund and the remaining term of the notes. However, none of us, MLPF&amp;S, BofAS or any of our respective affiliates is obligated to purchase your notes at any price or at any time, and we cannot assure you that we, MLPF&amp;S, BofAS or any of our respective affiliates will purchase your notes at a price that equals or exceeds the initial estimated value of the notes.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The value of the notes shown on your account statement produced by MLPF&amp;S will be based on BofAS&#8217;s estimate of the value of the notes if BofAS or another of its affiliates were to make a market in the notes, which it is not obligated to do. That estimate will be based upon the price that BofAS may pay for the notes in light of then-prevailing market conditions, and other considerations, as mentioned above, and will include transaction costs. At certain times, this price may be higher than or lower than the initial estimated value of the notes.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The distribution of the Note Prospectus in connection with these offers or sales will be solely for the purpose of providing investors with the description of the terms of the notes that was made available to investors in connection with their initial offering. Secondary market investors should not, and will not be authorized to, rely on the Note Prospectus for information regarding BNS or for any purpose other than that described in the immediately preceding sentence.</font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>14</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Structuring the Notes</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes are our unsecured senior debt securities, the return on which is linked to the performance of the Underlying Fund. As is the case for all of our debt securities, including our market-linked notes, the economic terms of the notes reflect our actual or perceived creditworthiness at the time of pricing. The internal funding rate we use in pricing the market-linked note is typically lower than the rate we would pay when we issue conventional fixed-rate debt securities of comparable maturity. This generally relatively lower internal funding rate, which is reflected in the economic terms of the notes, along with the fees and charges associated with market-linked notes, resulted in the initial estimated value of the notes on the pricing date being less than their public offering price.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Payments on the notes, including the amount you receive at maturity or upon an automatic call,</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>will be calculated based on the performance of the Underlying Fund and the $10 per unit principal amount. In order to meet these payment obligations, at the time we issue the notes, we may choose to enter into certain hedging arrangements (which may include call options, put options or other derivatives) with BofAS or one of its affiliates. The terms of these hedging arrangements are determined by seeking bids from market participants, including MLPF&amp;S, BofAS and its affiliates, and take into account a number of factors, including our creditworthiness, interest rate movements, the volatility of the Underlying Fund, the tenor of the notes and the tenor of the hedging arrangements. The economic terms of the notes and their initial estimated value depend in part on the terms of these hedging arrangements.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>BofAS has advised us that the hedging arrangements will include a hedging related charge of approximately $0.05 per unit, reflecting an estimated profit to be credited to BofAS from these transactions. Since hedging entails risk and may be influenced by unpredictable market forces, additional profits and losses from these hedging arrangements may be realized by BofAS or any third party hedge providers.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>For further information, see &#8220;Risk Factors&#8221; beginning on page PS-7 and &#8220;Use of Proceeds and Hedging&#8221; on page PS-22 of product supplement EQUITY STR-1.</font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>15</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; text-align: justify; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Summary of Canadian Federal Income Tax Consequences</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>See &#8220;Supplemental Discussion of Canadian Federal Income Tax Consequences&#8221; in product supplement EQUITY STR-1. In addition to the assumptions, limitations and conditions described therein, such discussion assumes that no amount paid or payable to a Non-Resident Holder will be the deduction component of a &#8220;hybrid mismatch arrangement&#8221; under which the payment arises within the meaning of paragraph 18.4(3)(b) of the Act.</font></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; text-align: justify; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Summary of U.S. Federal Income Tax Consequences</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The following is a general description of certain U.S. federal tax considerations relating to the notes. Prospective purchasers of the notes should consult their tax advisors as to the consequences under the tax laws of the country of which they are residents for tax purposes and the tax laws of the U.S. of acquiring, holding and disposing of the notes and receiving payments under the notes. This summary is based upon the law as in effect on the date of this document and is subject to any change in law that may take effect after such date. We urge you to read the more detailed discussion in the &#8220;Material U.S. Federal Income Tax Consequences&#8221; section beginning on page PS-41 of product supplement EQUITY STR-1.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>No statutory, regulatory, judicial or administrative authority directly discusses how the notes should be treated for U.S. federal income tax purposes. As a result, the U.S. federal income tax consequences of your investment in the notes are uncertain. Accordingly, we urge you to consult your tax advisor as to the tax consequences of your investment in the notes (and of having agreed to the required tax treatment of your notes described below) and as to the application of state, local or other tax laws to your investment in your notes and the possible effects of changes in federal or other tax laws.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Pursuant to the terms of the notes, BNS and you agree, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to characterize your notes as prepaid derivative contracts with respect to the Underlying Fund. If your notes are so treated, subject to the discussion below regarding Section 1260 of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) you should generally recognize long-term capital gain or loss if you hold your notes for more than one year (and, otherwise, short-term capital gain or loss) upon the taxable disposition (including cash settlement) of your notes in an amount equal to the difference between the amount you receive at such time and the amount you paid for your notes. The deductibility of capital losses is subject to limitations.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>However, it is possible that the Internal Revenue Service (the &#8220;IRS&#8221;) could assert that your holding period in respect of your notes should end on the date on which the amount you are entitled to receive upon maturity or automatic call of your notes is determined, even though you will not receive any amounts from BNS in respect of your notes prior to the maturity or automatic call of your notes. In such case, you may be treated as having a holding period in respect of your notes prior to the maturity or automatic call of your notes, and such holding period may be treated as less than one year even if you receive cash upon the maturity or automatic call of your notes at a time that is more than one year after the beginning of your holding period.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Although uncertain, it is possible that the Call Premium, or proceeds received from the taxable disposition of your notes prior to the Call Settlement Date that could be attributed to the expected Call Premium, could be treated as ordinary income. You should consult your tax advisor regarding this risk.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Section 1260</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>. Because the Underlying Fund would be treated as a &#8220;pass-thru entity&#8221; for purposes of Section 1260 of the Code, it is possible that an investment in the notes could be treated as a &#8220;constructive ownership transaction&#8221; within the meaning of Section 1260 of the Code. If the notes were treated as a constructive ownership transaction, certain adverse U.S. federal income tax consequences could apply (i.e., all or a portion of any long-term capital gain that you recognize upon the taxable disposition of your notes could be recharacterized as ordinary income and you could be subject to an interest charge on deferred tax liability with respect to such recharacterized gain). We urge you to read the discussion concerning the possible treatment of the notes as a constructive ownership transaction under &#8220;Material U.S. Federal Income Tax Consequences &#8212; Section 1260&#8221; of product supplement EQUITY STR-1.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion that it would be reasonable to treat your notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the notes, it is possible that your notes could alternatively be treated for tax purposes as a single contingent payment debt instrument or pursuant to some other characterization (including possible treatment as a &#8220;constructive ownership transaction&#8221; under Section 1260 of the Code), such that the timing and character of your income from the notes could differ materially and adversely from the treatment described above.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Notice 2008-2. </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>In 2007, the IRS released a notice that may affect the taxation of holders of the notes. According to Notice 2008-2, the IRS and the U.S. Department of the Treasury (the &#8220;Treasury&#8221;) are considering whether a holder of an instrument such as the notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible, however, that under such guidance, holders of the notes will ultimately be required to accrue income currently and this could be applied on a retroactive basis. According to the Notice, the IRS and the Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax on any deemed income accruals, and whether the special &#8220;constructive ownership rules&#8221; of Section 1260 of the Code (discussed above) should be applied to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the significance, and the potential impact, of the above considerations.</font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>16</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Proposed Legislation</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>. In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of notes purchased after the bill was enacted to accrue interest income over the term of the notes despite the fact that there will be no interest payments over the term of the notes.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Furthermore, in 2013 the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect of this legislation generally would have been to require instruments such as the notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>It is impossible to predict what any such legislation or administrative or regulatory guidance might provide, and whether the effective date of any legislation or guidance will affect securities that were issued before the date that such legislation or guidance is issued. You are urged to consult your tax advisor as to the possibility that any legislative or administrative action may adversely affect the tax treatment of your notes.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Medicare Tax on Net Investment Income.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a portion of their &#8220;net investment income,&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the notes, to the extent of their net investment income or undistributed net investment income (as the case may be) that, when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), $125,000 for a married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the regular income tax. U.S. holders should consult their tax advisors with respect to the 3.8% Medicare tax.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Specified Foreign Financial Assets</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>. U.S. holders may be subject to reporting obligations with respect to their notes if they do not hold their notes in an account maintained by a financial institution and the aggregate value of their notes and certain other &#8220;specified foreign financial assets&#8221; (applying certain attribution rules) exceeds an applicable threshold. Significant penalties can apply if a U.S. holder is required to disclose its notes and fails to do so.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Backup Withholding and Information Reporting</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>. The proceeds received from a taxable disposition of the notes will be subject to information reporting unless you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if you are a U.S. holder) or meet certain other conditions.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Amounts withheld under the backup withholding rules are not additional taxes and may be refunded or credited against your U.S. federal income tax liability, provided the required information is furnished to the IRS.</font></FONT></P>
                <P style="margin-top: 4.4pt; text-align: justify; margin-bottom: 0; "><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Non-U.S. Holders.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> If you are a non-U.S. holder, subject to Section 871(m) of the Code and FATCA, discussed below, you should generally not be subject to generally applicable information reporting and backup withholding requirements with respect to payments on your notes if you comply with certain certification and identification requirements as to your non-U.S. status including providing us (and/or the applicable withholding agent) a properly executed and fully completed applicable IRS Form W-8. Subject to Section 897 of the Code and Section 871(m) of the Code, discussed below, gain realized from the taxable disposition of a note generally should not be subject to U.S. tax unless (i) such gain is effectively connected with a trade or business conducted by you in the U.S., (ii) you are a non-resident alien individual and are present in the U.S. for 183 days or more during the taxable year of such taxable disposition and certain other conditions are satisfied or (iii) you have certain other present or former connections with the U.S.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Section 897. </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We will not attempt to ascertain whether the Underlying Fund would be treated as a &#8220;United States real property holding corporation&#8221; (&#8220;USRPHC&#8221;) within the meaning of Section 897 of the Code. We also have not attempted to determine whether the notes should be treated as &#8220;United States real property interests&#8221; (&#8220;USRPI&#8221;) as defined in Section 897 of the Code. If the Underlying Fund and/or the notes were so treated, certain adverse U.S. federal income tax consequences could possibly apply, including subjecting any gain realized by a non-U.S. holder in respect of the notes upon a taxable disposition (including cash settlement) of the notes to U.S. federal income tax on a net basis, and the proceeds from such a taxable disposition to a withholding tax. Non-U.S. holders should consult their tax advisors regarding the potential treatment of the Underlying Fund as a USRPHC and/or the notes as USRPI.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Section 871(m).</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the Code on certain &#8220;dividend equivalents&#8221; paid or deemed paid to a non-U.S. holder with respect to a &#8220;specified equity-linked instrument&#8221; that references one or more dividend-paying U.S. equity securities or indices containing U.S. equity securities. The withholding tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked instruments that have a delta of one (&#8220;delta-one specified equity-linked instruments&#8221;) issued after 2016 and to all dividend equivalents paid or deemed paid&#160;on all other specified equity-linked instruments issued after 2017. However, the IRS has issued guidance that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments that are not delta-one specified equity-linked instruments and are issued before January 1, 2027.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Based on our determination that the notes are not &#8220;delta-one&#8221; with respect to the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>,</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> our special U.S. tax counsel is of the opinion that the notes should not be delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Furthermore, the application of Section 871(m) of the Code will depend on our determinations on the date the terms of the notes are set. If withholding is required, we will not make payments of any additional amounts.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Nevertheless, after the date the terms are set, it is possible that your notes could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>or your notes, and following such occurrence your notes could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also possible that withholding tax or other tax under Section 871(m) of the Code could apply to the notes under these rules if you enter, or have entered, into certain </font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>17</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>other transactions in respect of the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>or the notes. If you enter, or have entered, into other transactions in respect of the Underlying Fund</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>or the notes, you should consult your tax advisor regarding the application of Section 871(m) of the Code to your notes in the context of your other transactions.</font></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 0.0pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-weight: normal; color: black; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the notes, you are urged to consult your tax advisor regarding the potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the notes.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>U.S. Federal Estate Tax Treatment of Non-U.S. Holders.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> A note may be subject to U.S. federal estate tax if an individual non-U.S. holder holds the note at the time of his or her death. The gross estate of a non-U.S. holder domiciled outside the U.S. includes only property situated in the U.S. Individual non-U.S. holders should consult their tax advisors regarding the U.S. federal estate tax consequences of holding the notes at death.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-style: italic; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>FATCA.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> The Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;) was enacted on March 18, 2010, and imposes a 30% U.S. withholding tax on &#8220;withholdable payments&#8221; (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends or other fixed or determinable annual or periodical gain, profits and income, and the gross proceeds from a disposition of property of a type which can produce U.S.-source interest or dividends) and &#8220;passthru payments&#8221; (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their affiliates) unless the payee foreign financial institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account at the institution (or the relevant affiliate) and to annually report certain information about such account. FATCA also requires withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S. owners (or do not certify that they do not have any substantial U.S. owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to certain &#8220;withholdable payments&#8221;, will not apply to gross proceeds on a sale or disposition, and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations defining the term &#8220;foreign passthru payment&#8221; are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial institutions and non-financial foreign entities located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.</font></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Investors should consult their own advisors about the application of FATCA, in particular if they may be classified as financial institutions (or if they hold their notes through a foreign entity) under the FATCA rules.</font></FONT></P>
                <P style="text-align: justify; margin-top: 5.5pt; margin-bottom: 0; "><FONT style="font-weight: bold; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Both U.S. and non-U.S. holders should consult their tax advisors regarding the U.S. federal income tax consequences of an investment in the notes, as well as any tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction (including that of BNS).</font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>18</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 595.21pt; padding: 31.19pt 39.00pt 0 39.00pt; min-height: 48.02pt; position: relative; ">
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 26.62pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  4.50pt solid #5B862B; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 16.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 14pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; color: #5B862B; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Linked to the Global X Uranium ETF due December 30, 2030</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="font-size: 8.0pt; font-family: Arial, sans-serif; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 10pt 39.00pt 10pt 39.00pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; text-align: justify; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Validity of the Notes</font></FONT></P>
                <P style="margin-top: 5.5pt; margin-bottom: 1.65pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-weight: normal; color: black; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special counsel to BNS, when the notes offered by this term sheet have been executed and issued by BNS and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the notes will be valid and binding obligations of BNS, enforceable against BNS in accordance with their terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity).&#8239; This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law, Fried, Frank, Harris, Shriver &amp; Jacobson LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by Osler, Hoskin &amp; Harcourt LLP, Canadian legal counsel for BNS, in its opinion expressed below.&#8239; In addition, this opinion is subject to customary assumptions about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the notes, authentication of the notes and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP dated October 9, 2024 filed with the SEC as Exhibit 5.3 to the Registration Statement on Form F-3 on October 9, 2024.</font></FONT></P>
                <P style="margin-top: 5.5pt; margin-bottom: 0.0pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-weight: normal; color: black; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>In the opinion of Osler, Hoskin &amp; Harcourt LLP, the issue and sale of the notes has been duly authorized by all necessary corporate action of BNS in conformity with the Indenture, and when the notes have been duly executed, authenticated and issued in accordance with the Indenture, and delivered against payment therefor, the notes will be validly issued and, to the extent validity of the notes is a matter governed by the laws of the Province of Ontario or the federal laws of Canada applicable therein, will be valid obligations of BNS, subject to the following limitations (i) the enforceability of the Indenture may be limited by the Canada Deposit Insurance Corporation Act (Canada), the Winding-up and Restructuring Act (Canada) and bankruptcy, insolvency, reorganization, receivership, preference, moratorium, arrangement or winding-up laws or other similar laws affecting the enforcement of creditors&#8217; rights generally; (ii) the enforceability of the Indenture may be limited by equitable principles, including the principle that equitable remedies such as specific performance and injunction may only be granted in the discretion of a court of competent jurisdiction; (iii) pursuant to the Currency Act (Canada) a judgment by a Canadian court must be awarded in Canadian currency and that such judgment may be based on a rate of exchange in existence on a day other than the day of payment; and (iv) the enforceability of the Indenture will be subject to the limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the Indenture to be unenforceable as an attempt to vary or exclude a limitation period under that Act. This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable therein. In addition, this opinion is subject to customary assumptions about the Trustees&#8217; authorization, execution and delivery of the Indenture and the genuineness of signatures and certain factual matters, all as stated in the letter of such counsel dated October 9, 2024, which has been filed as Exhibit 5.2 to BNS&#8217; Form F-3 filed with the SEC on October 9, 2024.</font></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 6.6pt; text-align: justify; "><FONT style="color: #5B862B; font-size: 20.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Where You Can Find More Information</font></FONT></P>
                <P style="text-align: justify; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We have filed a registration statement (including a product supplement, a prospectus supplement and a prospectus) with the SEC for the offering to which this term sheet relates. You should read the Note Prospectus, including this term sheet, and the other documents that we have filed with the SEC, for more complete information about us and this offering. You may get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, we, any agent, or any dealer participating in this offering will arrange to send you these documents if you so request by calling MLPF&amp;S or BofAS toll-free at 1-800-294-1322.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>&#8220;Strategic Accelerated Redemption Securities</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>&#8221; are registered service marks of Bank of America Corporation, the parent company of MLPF&amp;S and BofAS.</font></FONT></P>
            </DIV>
            <DIV style="width: 595.21pt; padding: 0 39.00pt 23.43pt 39.00pt; min-height: 23.38pt; position: relative; ">
                <P style="text-align: left; margin-top: 0; margin-bottom: 0; "><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Autocallable Strategic Accelerated Redemption Securities</font></FONT><FONT style="color: #5B862B; vertical-align: super; font-family: Arial, sans-serif; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; width: 255.76pt; display: inline-block; ">&nbsp;</FONT><FONT style="color: #5B862B; font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>TS-</font><FONT>19</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
    </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>ex-filingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:bns="http://scotiabank.com/20251215">
<head>
     <title>EX Filing Fees</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_027_FFD%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_bns_scotiabank.com_20251215 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20251215_20251215 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0000009631 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Arial, Helvetica, Sans-Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-12-15" id="Fact000003" name="dei:EntityCentralIndexKey">0000009631</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-12-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000009631</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-12-15</xbrli:startDate>
        <xbrli:endDate>2025-12-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: times new roman; font-size: 12pt"><b>Exhibit
107.1</b></span></p>



<p style="font: 12pt/14pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><b>CALCULATION OF FILING FEE TABLES</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 6pt; margin-bottom: 6pt"><span id="xdx_902_effd--FormTp_c20251215__20251215_zn8QzqiHcHA8" style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b><ix:nonNumeric contextRef="AsOf2025-12-15" id="Fact000009" name="ffd:FormTp">F-3</ix:nonNumeric></b></span></p>

<p style="font: 12pt/14pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><b><span id="xdx_909_edei--EntityRegistrantName_c20251215__20251215_zc8bf2JxVz5f"><ix:nonNumeric contextRef="AsOf2025-12-15" id="Fact000010" name="dei:EntityRegistrantName">BANK OF NOVA SCOTIA</ix:nonNumeric></span></b></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 6pt; margin-bottom: 6pt"></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; visibility: hidden; text-indent: 0in"><span style="visibility: hidden; font-family: Times New Roman, Times, Serif; font-size: 10pt">Submission Type: <span id="xdx_902_effd--SubmissnTp_c20251215__20251215_zEBlDhJQRa1b" style="visibility: hidden"><ix:nonNumeric contextRef="AsOf2025-12-15" id="Fact000011" name="ffd:SubmissnTp">424B2</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; visibility: hidden; text-align: left"><span id="xdx_903_effd--FeeExhibitTp_c20251215__20251215_zeqjXCQ7fB0i" style="visibility: hidden"><ix:nonNumeric contextRef="AsOf2025-12-15" id="Fact000012" name="ffd:FeeExhibitTp">EX-FILING FEES</ix:nonNumeric></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; visibility: hidden; text-indent: 0in"><span style="visibility: hidden; font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC File No. <span id="xdx_90A_effd--RegnFileNb_c20251215__20251215_zh1PO7l420jc" style="visibility: hidden"><ix:nonNumeric contextRef="AsOf2025-12-15" id="Fact000013" name="ffd:RegnFileNb">333-282565</ix:nonNumeric></span></span></p>



<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; visibility: hidden; text-indent: 0in"><span style="visibility: hidden; font-family: Times New Roman, Times, Serif; font-size: 10pt">Final Prospectus: <span id="xdx_901_effd--FnlPrspctsFlg_c20251215__20251215_zUaxlWl2lrA9" style="visibility: hidden"><ix:nonNumeric contextRef="AsOf2025-12-15" format="ixt:booleantrue" id="Fact000014" name="ffd:FnlPrspctsFlg">True</ix:nonNumeric></span></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; visibility: hidden"><span><span id="xdx_905_effd--OfferingTableNa_c20251215__20251215_zLrWvZbeQkF"><span id="xdx_90D_effd--OffsetTableNa_c20251215__20251215_zWXYfCMKjbca" style="visibility: hidden"><span id="xdx_907_effd--CombinedProspectusTableNa_c20251215__20251215_zOGVgdGfnka9"><ix:nonNumeric contextRef="AsOf2025-12-15" id="Fact000015" name="ffd:OfferingTableNa"><ix:nonNumeric contextRef="AsOf2025-12-15" id="Fact000016" name="ffd:OffsetTableNa"><ix:nonNumeric contextRef="AsOf2025-12-15" id="Fact000017" name="ffd:CombinedProspectusTableNa">N/A</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span>&#160;</span></p>




<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0; visibility: hidden"></p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 100%; margin-top: 3pt; margin-bottom: 3pt"/>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0"></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0"><span id="xdx_902_effd--NrrtvDsclsr_c20251215__20251215_zBHuKciY3nZ3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-12-15" escape="true" id="Fact000018" name="ffd:NrrtvDsclsr">The term sheet to which this Exhibit is attached is a final prospectus for the related offering.</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maximum aggregate offering price for such offering is $</span><span id="xdx_902_effd--NrrtvMaxAggtOfferingPric_c20251215__20251215_zNCoMZnRY152" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" contextRef="AsOf2025-12-15" id="Fact000019" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,391,420</ix:nonFraction></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. </span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwkAMhE/QO4R9lv4qSh8tKmKVUkR8XWyUxXZTsutPj+Qt3baIIRDCzDcjxERsaK1qZDgvyxyO2LS1tAglXpFRX9A5su0uBXdLvCljWWo7vD8wI8egY2Z+nEgnDNanMlilEM6DaBHEUwiTNIqh2Auv1zPSV1WhtkrWIHUFBVPLCq3kbkw4yjdparqh6oRsFOkUIj8c5Q/Eocs70FO+iO8G8jwT3mQYT2yYHq1zrd4WdU/CqsbG1ZmR/q/3BQhMSo8= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image1.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image1.gif
M1TE&.#EAX0%$ /4      +0N+KXM++0R+KTP+JXY-Z<]/:T^/+0T,[TS,K4X
M-KPX-[0Z.KPY.<TG)LTG*<4M+,PL*],G)M\G)M(H)MXH)]0M+=PL*\4Q+\PQ
M+M0P+]LP+L<O,LPO,=0O,-TN,,0S,\LR,L,X-<LX-L<[.<@Z.=(Q,=DQ,.(G
M)NLG)N,H)^LH)^0K*NPJ*?(G)O(H)_LI)_ F*/(J*?LK*N P+^HP+_ P+^0Q
M,.HQ,                            "'Y! $     (?\+26UA9V5-86=I
M8VL.9V%M;6$],"XT-30U-#4 +     #A 40   ;_0(!P2"P:C\BD<LEL.I_0
MJ'1*K5JOV*QVR^UZO\6*)0("A4*@# 7,;KNCEDPHHWG;[_B\?G_OF$XL*H(J
M+!45@BPK-!L68WR/D$LA-"R!+"TW(9%3"1%C% \.$12C%!";J*E%GA:B$0X/
MKXVGJE F%XDM+3*\,KN^,B^^+2LJ%Q<FM<IV%[^]O"S)RTHF+3$I*(+9*+L;
M"]/@=P\L,BLHY]HJO"KA22$?NKPK*RDI*O;X]2GSSRTL=>T"5K'08D8Y>_=D
MS&"A2> 0$S-FN. 5HU=$&B <:M1B(47$%A,G\HK(8J,00 IE8#LW@67+"14F
MR&R9+44O72=,ZD3"8L8+_Q7G4,A4X6+&!9/5KF5+5Q#CSJ=0+*B 46SIH'5(
M"\I@(52FRZ TA09%4>'<BH@X&D+564V&"J\LL_D"Z+":O9=B5\C8D'&MWR0=
M7:0H.Q:%BQ85-E:;8:YKX<>0'4/[J_/$KJ"$SY%K86%C"&)O"Z=H<2$!Y=-$
MQKDH]+A<XKJ[JH;%&S;R6)L,46NLUD*LV*$Q.&_L, \H6!0V2^M&'<&F\;@H
M7#O44'#EV-I@\1*.B<[%BL[+V9S 88/%#7^8SN.@T:2M;5W@81?#GMQT^+\6
MR U^O *QP P7^/(63=AA5QB!*NQRU'U@]&10/+OL8I $3+0%5&T3J"/<;HD\
M1_]3<GTQ"-4#*;B@ F$PG4,,"@)ML M7D+W4TB#S(&1<2R]*(V(7%SS8WSS]
M*=3"&I*0XX)C7GFTX70LF A72_7M"%5^*F46U&&OA1,".2O ==V'(D7X2POV
MG./+@E)R4<&*5F;SP@I$+K%8"T!=-8,-.0U7W(%Z72!"FCMU5.5QT:U04CLN
MRN";8T&IL,)A_ES0R#$0ZK656H!FT8PY,Z9H$YQ.!/A@"R^\8%">BH$65EG]
MG6!?IAJ-XU:;COH7#@1<QH5=@I%J@&D(Q_!JD >P;A'@?(6I ZH3+NJBRPHW
MZ*A8A[ZUU.>KQ08DE8GG6*E7EM.8H-> !PH2:8A(F,#_ @XW9*M%!>5<Z!MN
M<381@@9_:!"?3AHT&1I+CLJ@G+O:ZI<93=*%LVEH>*&C"YI,H$MP%<W0.9M<
MRV:K[I'\"8SMQ,N0N-JN_8&[S+'_BD8:R'FL695H*M4+J[B-7=??P"PO0V4*
M7N'EB\FU++"!8"="EXVA=.7L!KS<BO8FA>YN6;-O?4JL-"H6Z,5SMU?V%LX(
M-!#]Y03CTG)U&T8*@LU**5 %=;;Y.7G<M6?7(FO*8ND"M"KJJ@19!<Z97?<7
MFT*FGP,$>Y (9.I\\/'@CV3=M&^\L@C.)&[]1A:46T4PC0@EF&#"""6P 4+H
MN$13PI];%&#"!Y)Z,&DCL%M@__4F"900P@B8;K'QHF:1]O@0(HB@;K2WWR$"
M"+RSKHP((VBPP0DC),_$ ^IL71B6X8BP@=\&WL/"OI#<4LDQ-U3"0NH;]%Z%
M^>N?YVSJT;K?1 F\@R "!R%X8$((?NB !3S0@0AXP%=E8-X(D+ \-"10?V@8
M00.N\(=(?: 2Z6/!!C)@A :,8 3_"T$(1<@[)(1@3W.3P0FL-@)<5. 2NC!/
M)4X@+3#T[WS'D.'Z:G@2$.[N?Q_\(1(:\, BBN ,Z0)$)6B@BPQ^ %5.D(I;
M"-0URRT!>@XLP_(2N+L0,( +%R :%8,RFG] H@,7O,0S9%"1?E1B U4(@05N
M$*0UKO_1'^NS7Q(P8!D<'N,"%3A&(/_XQ_6QH 8M@*,13("#\SFR$C@XP02E
M8 $E.H,BO#A,#4Z *1/4 )&7H$$*+E$#&] @ $>@&;GR(K B*,X9!J%(+&,(
ML2WT+WV7O.,*:$B$2]B@!I=07W]^64LA>!*8N$@F+FH0K2*80'ZQY(4SFDBL
M*!KL,7IC0@1ND+X7&C*9E:B!"89',=#$*!NK2=H=3H"+7WB''C821!U]P0(H
MVFL#:I3!8>KQG'/4XU'>,88>C0 !&<  !BX0VS:L8Y42320B*S#""&X0$7UF
M4D(SJ,$"H1""#23HHORD49#\H:,3V."@"2V5"TS%& $<07'_+XM+GX:@@688
M) 8U&H0^2@2-:-B2G98B!CWNH3:>;D61 ' !#&: T)26Z@4'98<13A"1A.XB
M!A4IBE&(@(M,_E-MR,&JD#XP4")(KDMCW,7>B( !![%Q(K%A8T4_T(5$>0A)
MR/%.!<K*A0XT@XTJ*9-M_#G2#? P7>3P14RO,Q:UN: B9F0"!%H  VR =1!
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M!P"355'Q@EG;T%QMI! S> 3G80XH$CQMB 3-\'5/@A=J1 R!@ TL\&S=DF;
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M7PY'B[WQ?>)W=WRP 3101ZI%A&+AH[S@FT=@@]GV$D2WJ,ZT44@ (.##6.K
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MR0O2T5P-;XHPB!P%E8,A920QEH)P'^PY@GUTBV+),?IIC+49BNT$.]U@WT(
M^KL:/(H7@R!W)J9;#5T7>^*[*L'<0Q =2IC96Y<% M#)=JL"?XP$NPUQY^<F
MN9$$#]VY8)T$+@*W$/AAQFH9BD* )$4%-RG((.<6OPUS_]LSW%"@R%3DSEK:
M2TL*/,3 Q"$,X$'AN4: F?=-I.ILW5PB:<%S =H]Q<XQV1EB@.%3UG[1+'?5
M'2R WL=*Q)FM(A!^!0E2Q79KRU'A+RG<.7*LT*#=W^QI'61=VTE;X+2Q&1I^
MJ@1Z?@$3L['I+P9[OXHZNZ^:/6!G$]OF3/%G-*8\!<1ABM5<TS'JW(WB+#JM
M C@E?R63XL0GV0>RE8%P< "[%D+ZULIBXT*0VG3G"^-]RW ('7AZRU1($Q]L
MO,Q[()\2S$I*>N1P 2O\(HNL ER>OK\;&8>;N'-M81DR#VP]Q-3L$F5.!,X\
MPN\VWZ>*R2@'W32UL%^B++NJ!/\. *^5"R4MQYKX:B#V( $8D. '$A/BY^I?
M$ (G8-FG^LKAH]1)ZP]_%T,8L 74$0/KNL/^4.K4D-<I=.M<A=F-$C.)6+^9
MP;>7[J)/PBNGC03YX=4+;>6?)^ZW09!0L+E(]\!A0-$UF]]/T"_F!QDB;'3H
M[%S5W00.H,B0+C#>2[5P01B"L2"78")O+1/BE[E:L '$]+CDVHH_CK<  &?J
M!3P]'K!3<), OI-INR4!52Z^T.Y=O6LDC.1'@-:+PBJ80+V*6[JZ0C9;$>7O
MZC?:*D\,+JV[KIBM$@7<)UN-XAV']5=IJI@:C+.) ._HX.'GO*YU??!,0 $\
M_QL* MG_)&F^P&7-RSFR]FN,&-_94R J,T@:S!X!%[ /,M\M:$N*"F\T[!Y%
M?XRL60?7F&LO37(DN,HVY=#WQ[<K):RVC6$E-K%_O/K7,*,"@-Z+!5$5TQ4(
MCL)YB=LO<L,X*_D$801QZ9 .KV@_%GN6C]$DNYL$<O\H[^6Q-F$B!+^"BCD,
M4$ !7M[3C[W=(]_;5D3@-W@Q$U'!#A<"$5"9FPZY@14A^%F3(+ !0%O$QW$8
MSI<H"-<27.*G2D =F]3]WDXYR\KM5KJV "@4Z/N;.DO:Y0#;X6X= <SD.HCF
MWV[9-:4+H N-AZ 9#%^Q>%EY0#!1Q5:7$ "95 ) %M9*-1%6_U14ZJKU62I9
MLA8*C)J QRGO!;1=ABZL;P6EJL[EE=97O5FMPF"XRHM%;1!  I"O;PSK F+K
MP4RE+ZR%3TEC188E;FQ,#+!E@U M)"0-P"(B \14%*!+1@HEY2[PPL+"ZO;B
M+D4R4<A+8] ",ZHS406+Q8-5R<1M9H;%@C"D"\HWKN7,1(VAZ<+VUD+<0B+<
MJ!7 CN\8#)"%0AU@0Z;7UXR&9/!:S!\N%A85%S@,^F8BW#AQY<A=,!$A@!H3
ME/Q)XC0!2XL+&IHI:6!"0S@-XRR,O!72Q)%!&[89"S/FCXLBP@8U8"/2),EQ
M(3?07**!4B0X85ZUF)=$@ID5 /UA+/\B8(L3>T,K#/6"8LDN&2B&OI0E8T6H
M>2%&=&2"P>P2EC*,==H3PPLE+$2VM;@W]%BL%M)$=7%1T5<RL"PJ.$1XP0ZE
M%)A:4!LT,9,[,6/J$@Y'JE0($QY*CN-\*X('$RGG[8(B6<6+%@[FU;L'V(V^
M04#92L*+@C$+6R%$K.H]PL2)""8LA,B@8;2%#!$L<$:>%L S;-DXQ8'+0L6M
M4B*XBPBA ?SQ6QDLI$0^&CH2#OTD<]76@K#HWKY!:$:^/+P&\LF/AU<#]*\^
M_HCK*"0, 2L;3"Z :@D+%DNAJTGP4 *$?@1TSPP6NFD%A R2&($4$9!8113:
M5NB$$RI46,S_!1E<E.$%%^X*XS:NS&C!)S4R8&&&2&)ISPP7X1O213[@V(8%
ME=2@X:J+)'E"R!9H8(%**@M#)YPKV]!(25$N0+"Z,528805YU'&C%\GRV6>0
M+V&I[I=D7L@$NS9TPS)+=+2<(,MI(MI" Q9<<&DRBX0($C[=JKQ33RP+LT#*
M$Q9H9:(>PY1D12$5M=,R+1W5DT\JQ6J0(E^ZN*/ 0JZ)I8]%&%3B@2X@],6%
M%BK8(H1M_H)SDDS2.RL)XE )85(F$ABD0C!]<9(Z.&$B P47:5!GET$!R^N=
M/>):H1<?X<"$ABXMV::7KE!+@4499$+W'3DBB02W%B\X*C%X^U#*_\Q6OOS"
M%TQ.*(&00!&LD559L'"A177W<+>7AF4!XY[%8$#A524ZV".;C,$X6-TBN7W8
MX3CB6&$&&4XH3888".T$("&20;CCH%)P%Y\5WX6!K?^"2B0.(5.5 ),3O<)(
MHXJ1<- >=Q21X=:H:K 'L HZD5<4##!(H@/'(F!%1#5.:&%0%*,F@ZGVEL4M
M$W'Y<3$*P-SNPUY,7=P .@W89LHKN-V-.PYXX761A0Z.,@W>ZE)+(5]1OKY'
M;$!N )@02&> ,,*\&;9YYG?"D".,UP1#H9$M)FJ'9XW[7G'FUVJ6 V>CQL)!
M6=,9GGGOOD'>G//4!M79VML^$:3  Q')2_]!HP%X0 6[>(UVJ<>0; K:3TX>
MQC$ 0H@ B5*22,O-MB_-1FILS\9MAALV5.>9DJ%=?WWQR1#3BU&W<)/TEYRE
M$?PP7)!&;4*^1$02^)K'"6(7!G^QB1 ;L(&,6,4K*1Q#:NZY5^UD$8G%],AX
MT7D"WXZQ-YIICG.=TQSM4M B%F#O*)([$<O\( :JV.]:<M#$P_9FAMT!:F?_
MZ)D7?F:ABA"M L:S@ I<,$-W4*)I:G!3Z<K@A?/]I'HIJ4^7+/" ^44#0FVS
M"/1*5ZC) ,.)J7)"R=J2-_<M:P(IB(;\EL"DI!6,?:9S#Q%AD*14F>9M\$B<
M_^SRPXVUX 8()$3_%UZ0@@=V48*_.%0*9EBZ+@3Q/X(B%-RX%;<Z/ F-<6B1
M"D)7(!6^#7]YD\0>EB(@>]T!*X!:F&T 40/7'24I"');\:(BJPB-H59)Q-6I
M-%:7$8S"0]E#A0>4!)JH;&,PT+K?^ *#3 VEZFBO@$+<S/:L?I5L>FJHT#:@
M@#=EBHULG0-<_[P$%KY]!7'SZ$?EL!#(U@BI?:+$E!RXE1 \86D:Q]K"Q:8#
MMSC8(B0[Z0DY2F*2D>2$'!_X@ :N!DT :"43<53F+[0!A7MNY)XZZR=7J!"(
MGS'&;6F4P8*B8@;53<(%NMS"CL!2L&-@@@4%64("6!$"*V9 2<L91 AN_X#,
M%O@H8P[DV0K@DHDGIBI0=>&<9):WOB#5@(UYV$MMFDJ==[2H".0L)R(LR18)
MM*94 1PIY-2Q%JHR$PY500'84L!0S=P"),GQP E @@")! 4U P'! C33D_ <
MQSCY <]H$%(>WCA4"9 JDAS=]HD*:$98@SW/!D"2HR0 93HL"Q+P"B2K9;G*
M$6A"T5#NH%(<GO5"+IK7%FB*A*X!X+4X%<4S7F&/PFW1'7*8A0QF )]L(A8)
MM'%1YN+I-BCUUH[S> 8R-\JL>[VH!;^]H[IHYBZ2K:!ZHJA';7(GF,<5Z&M[
M^5AQ-V>&WJYV!&ZH F+"H0(W7.!/2YB(C#SXBO\+* "V&Z!!#2QCBWMNP$XX
MB&X(&@!<9_1T!H6L@UK%1\22L2 -N_AI>]OK!L+D05VTRQVB4H41!-6W114@
M0$E?,,T:NBB5VI4!##3\+C!LPP;290(IU*  $*"P%1YP S)K!05T82X9R=B#
M3UGP :U",SBT\ *W2(BYW6I*QAQR W13]V/=+F8%"9/245,UII(555TM@$%O
MO]J*$O"H9"]Z431P0-:Q7  38?ZQAM'ETQ:<SP31@%G">-NC3BJ!@&E.&":B
MP=E V<!%)487NI@,,\!= ,<&#E9MF=QB1FMYM0 @F9Y;Y((7S"D:*O!:-+S@
MZ!;-P :OG,<$^JSF-<__X (-54($]M+;CG6LT"A+,#+57&L99#=[95G" DA4
M(!-\8$N\!AO82AV71%U@ T<&[K'=&V<AM4C9*] -7:=] ?<J&RR\#D1AI$VM
MJ[3+@F1B35G-Z<%,W>"UQO:VDFLE[CL4N1F0X0-VW+47%F0P RU!02/1EFDD
M; !*KH:NMJ<A.$F/ N%3#C.SM5SD)\;YIWM+N*AQ:*UVH0T^/PO2NTB>Y0N,
M> D1$-1)Y4 U=;!A9]7=&*QEO;WKX90W(M"G0R.@ 81KV[V:J !V9J$A#43Z
MX8/@0 >66P4J>#L9+#C!T9-NO1!$7(;NC0253B#;I$/@%@Z(0 0H$ &Q/P 5
MQD?!P"W*WO8'H'UK!O[.E A#I3E0B33#_L[8'S#VY3 '.@E@#@4>4/:Q.Z D
M?Y[T$PA#SP$CO>J PGJ=@JZ;_H%D[)D?>P@XHW@D)(#M?(_ VYD#['F4GN]B
M)_LM:C[K6_0]\P] O 4\CZS7CY[LN(>  RJ@@9VO85B17\?6ZK,*"#S X,*?
MQW@P P+D*W\)%=@:9M9N>NA?'_K*P0QSL/]P5-S8^MW/2@1(49\()%_\Z5?_
5^MG??O>_'_[QE__\Z5]_^R<]"  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image2.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image2.gif
M1TE&.#EALP'J /<   $! 0D'"!8' P4)%AL;&Q<5%Q$1%"<5"288%C(1"S,F
M%@@5)Q@:* H3,BT:*Q@E.10D,2PL+"4E)38E)3$O-D8:#5$N$V<X%4DG*$8I
M-E S+6LY*449)SEY #I$-79(&6U$%4%_ %5&,'E&*')-,UU*(PD82QDW6!,J
M2R<I1S@K1B\U4A@X9B\X:"P>2DDT2B]%6!M%<"A(:"=*=3E)>#A4>3%/<A]
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M^C#.]DNH;U]E5!3[QJ#O1;=GD^E=!;_M//P. '!$.RP0 WH(Y!Y-"  %*("
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MAO\X$$V0!];PD .A#Q/)D@4QD;W D1Y9E/O0"BI0#O'7<=3 "2@I$!T9#'0
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M"B*  4\*SP1,ST";Q1FZ"3K@BJ P 3"0#-1@ ?5J!'(LN;8  ^8I"BMP#G)
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M@DP8MK J4W#!&L]8Z!63)C:*$K6H"=O*VMAT!BV8P0Q86(,ZK$$%+7!+-]L
M@Q;4X 8P1(&.43!+O:XAABZLX0O3P\?_$<,00UZJPQ)1,$-M5*$%,:Q!"VZ
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M<=320 $/("(E[AA%/9@@Y'V$P@4&N4<1^&"54,!@'E8I @ "\(@FP, " &C
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M S_DP@'(7!PLP"[ 0QE  /LE "*H@W%^&?VMY3$T 0J 0S\, 0O, @4,PSZ
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M3H '^!<?U,,]1.2E(0.:3NDOM,/0!8 !* #H,0$%:,#:]2DC:!?4U4#W/8$
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MS3'A!25]@6#(0QA$@3.<PA1@@0E;@1GU2>!& 2;D UC8 X/ PA>0KH9L R9
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MS)=45?Z.!2O=AAE<0;I@0D?E@RH@_VX^(!!;,,,5C/(U< $P67<%?X6CP-6
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M 0M+<K) 2W3)$?1P.";\80D_)$$7V[&!+(*E'5S42"LFX $)"& &<$M# 0A
M !M [P@!"&D BIF-$0R@  '@@S[*$( !/*(5"0@I"CAY!P1(  $/(&@H4C#_
MCGN H 'E\,8&(&&'%,QC"(.(I$9N48$!($  )DC='0Y0@ (L0!C:N   6) \
M,A2  @@(0"#VT0XA&(  # C$"-\QA $0P  R.(<H$(  "A  $/2@1?!"J(\Z
M%  !(KV?*+(J 07< (4@N0,! A&,:?S,&R, :0$2@4@R&( !!*@<*AT$#7J4
M08?+F 8H$G"U;%R  0@H0"/@:82Y1H  C=@'* Y   2D@(]Q8( &"#  (&2
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MXHS<0M?)O( CLD$!\^WC=,=XQ0<UT@0GIE4$NJ## 'S-  %T$7[[1F M-O"
M"2  !>7X*PC_D L#^'JC?/"&"""1$3S X+L>(=P_EV$$&=2#"5/=:0!\$8H
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M'XS@!B;ADREA'+H'$@PO$#YA$BIA$R9O!7;F* M.D)6-"!8A&WIQM2 A&R9
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GP#NW";S #?S $3S!%7S!&;S!'?S!(3S")7S"*;S"+?S"@20@   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image3.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MHH **** "BBB@ HHHH **** "BBB@#A_VD?^2)Z]_P!<X_\ T:E8=;G[2/\
MR1/7O^N<?_HU*PZ  =:^1?V=?VE+7X/Z5\<M>\7:EJE]9:?\0IM-L(-YFDW.
M[B."($\#C.!P I/:OKH=:^,OAI\'[V_^'GQ^L]>^'^I^)+;5/'<]]:Z>9/L<
M]U#O?%Q;R'NH.01UY'>OF<^G7A7HSP^Z53HVK\CM=*[W\CAQ;FIQ<-]?R\CZ
M%^$W[13?$?Q=-X?U3P9XL\&ZU';&]2#5;<-%-#NVAEF3*;CUVYSC-<O^WM^T
MEKW[,_PGT_4O#^E?;;S5]173_M;X,5AE2PRO=WP0O8;23VKD/V01XRM/C'<V
MNE1^.K?X51Z:0T'BY,7-O>JVU4@)^8I@ Y/7YO:M_P#X*4_#C6OB5^S?'#H.
MGW&J76DZW::I+;0+NFDAC$@?8O\ $PW@X^M<]3&XNMDM:M3<O:).SLKZ=596
M:?1I+T3,Y5:DL+*2OS:]/Z_)'%_$+XXZQI?[=GPSOKS2O%6EV^I>#;F>?PNK
M>=<_:"]VJ1LBG8TF0OS=!@<\5Z[\-OVO= \;:;XM;5]/U7P;J7@6+[1KFG:J
MJ^=91%2ZOE3A@5 /']X"N"UW3]3\;?\ !13X9>+K?1-8@T.3P;<^;/<6Q06<
MC_:BL4O99/F7Y?<5QOCO]GWQ%\6?VA/VD].M[&]LH?%'A[38=+OI$*6]W-$E
ML_EJ_0@M'M;T!-<5/%8[#2J5*%Y\U62LUO\ NN9._2\HI:66KZVMFJE6#<H:
MWD]+;^[>_P!Z]#VKX9_M>Z;\0/&6DZ/?>&?$OA5O$T+W/AZYU2)5AUR%$5RT
M>TDJ=K [6YQ]:/V]=9O/#W['OCR]T^ZN+*\M[&-HIX)#')&?M$0R&'(X)'XU
MX+^S=^SU:W7Q9\!26_P_\8:3?>#4$^O:EK^JW!@M[J.- JV:9*NKMG(^Z%P.
MU>^?MWZ!?^*?V0O'6GZ79W.H:A=64:06]NADEE/VB(X51UX!/X5UT,9C,3E.
M)EB/BY9)63O\'^&.J=UHO*[:;-(U*L\/-SWL[?=Z+J?*?P5^&_@WQY-X37_A
MIKQ(?$FK?8W;1EG+-]J<(S6W(YPY*<FOI2X_;DM]0\<^.O#^C> _%GB#6/ ]
M\;2>#3_+87(R^Z0,<"-1MZ-DG/'0U\Z_!GXAZ9X"/A-?^&6-877M)%I$VM"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** .'_:1_Y(GKW_ %SC_P#1J5AUN?M(_P#)$]>_ZYQ_^C4K#H *CLM7@U>'
MS+6\M[R-&*;X)EE56'5<J2 1Z=JD!Q7RK\+_ !_#^RWK7[07A^XS#9^&FD\7
M:8G',-U&S$+Z_O1C';@5YV.S!86</:+W9<R;[-1<E]Z3_ QJUO9M7V=_RO\
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MM+]_,S=-_P""A6DS?LW:]XRFL[2?6?#^KGP^]A9W0EAN[TMMB,<G>-P"X/\
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ME:_N[#5[:A1114C"BBB@ HHHH **** "BBB@ HHHH X?]I'_ )(GKW_7./\
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M=2J3)8N^-S(<\$[5S]!6W14SIQFN6:37GY:K[GJ)Q3T844450PHHHH ****
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MO^"0'P1^#/[.GQ ^&>DZ/K4^D_%*T>Q\3ZGJ&KSWFM:K"4,:H]Y(3)M1&(0
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M]FWX@>,-6MM \(ZIX9\2^$/[3OI!#8VU_/\ 8[F!))6PJ&18)0"Q )4"IO\
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M44 %%%% !1110!P_[2/_ "1/7O\ KG'_ .C4K#K<_:1_Y(GKW_7./_T:E8=
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MS>]?WKWJ<UY:W6BTEY<NXU1KJ4+-VLKZ]>M]?T?R/"_ ?[1OC[Q5XXN8=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ437$4142.J]U7<N3VR*]>_X59X;_P"@'I?_ (#+_A7Q;\>/ &AP_P#!=_\
M9[M5TG3UMY?ACXM=XQ NUB+G3@"1[9/YF@#Z&_X3W0_^@QIW_?\ %'_">Z'_
M -!C3O\ O^*],_X59X;_ .@'I?\ X#+_ (4?\*L\-_\ 0#TO_P !E_PH \S_
M .$]T/\ Z#&G?]_Q1_PGNA_]!C3O^_XKTS_A5GAO_H!Z7_X#+_A1_P *L\-_
M] /2_P#P&7_"@#S/_A/=#_Z#&G?]_P 4?\)[H?\ T&-._P"_XKTS_A5GAO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7Q'\<7^U?\%^O@)$?E%K\*/%4P(_B+WFGKC\,5]N5\1?&?_E8$^!__
M &2+Q-_Z7V% 'V[1110 4444 %%%% !1110 4444 %%%% !1110!^64O[%)@
M_P""O%U\ X]:C3X!:TB_'Z[\)^2=KZI%=+:_8@?NBT>\*7C1XP7C Z5ZC^V=
M\*+S_@H%_P %-;+X"^(O&GC;PA\-?!OP\B\;7%CX8U5])NO$%_<7\MI&7N(_
MG\J!(B=HX+2\]J^IG_9-T63]M>/XX_VAJ/\ PD$7@UO!0L<K]D-LUXMV9>F?
M,WJ!UQBN#_;D_P"":N@_MG>+_#/B^R\:>-OA=\1/"<,UE8^*?"=Z+6_-E-S+
M:2;@5DB9@& 8':02,9-3&*5.E%J_*Y77_@48/SY8JG_X"NJ*E*\ZLD[.2C9_
M^ RG_P"!2]I_X%V/A:^^*WC;X=_LY^)_A/=>.->\1P_!/]H_PIX-T;Q#/>L=
M0OM)FNK&=+2YE7!E:))C Y.2X3YN<U]:^,?&6H)_P7D\%Z#'JUX-+;X,:A>S
M::MRWD&7^UHE29HLXW8#*&(S@$>M:\__  1Y^%MS^P?JWP(DN/$4ECKEZ-=O
MO$S7I.N7.MB59QJK3]?M F17_N@#: !3/V3/^"2WAO\ 9:_:'L_BO<>/OB!\
M0/B"- N?#VHZUXFOA=7&J02S0R1[\ !!"L(5%0 ?.Y.2Q-5334XN;ORMMONW
M05-^>LTY:]T][VSJ*\)<BM>R2[)5G/T^%VLNUMK%/_@H9XVN/V<?VLOV;_BI
M+JE[9>%VUV_\#^(X/.<6CQ:C9R/:2R)G;N2[MHE#$<><1WKX#^"O[1/Q,US]
MG_XF?#'5O%6L#QE^TMXN\->)?"$QNI%N=.TCQ%<2BYCMCG*+;6VGSM\O"[\\
M9K]7OVY_V.?#?[>_[,7B/X6^*KK4-/TKQ!]GD^VV#A+NQF@GCGCEB8]&#QCG
MT)'>N(U+_@EQ\.-0_:I^#?Q:5;VWUSX)^')/#.C6L946L]N8C'"TBX^]"'E*
M8[RM1A[*7[S;F7_@'QR7JYQ2])/Y:5I7C>&]M/\ &G:+].23T[Q1\-?M$ZYJ
M.H_![]I"QO-2U#4+;1/VF_"5A8I=7#3"U@6XT,B--Q.U<DG XRQ/>OKK]A#_
M )2+?MD?]C%X>_\ 3-%71>-/^"6_A#QMH/Q$T^XU[7XH_B-\1-.^(]ZR,FZV
MO+)[-XX8^/\ 5,;-,YY^9J].^#W[+ND?!GXX_%+QW8WU_<ZC\5KZQOM0@F(\
MFU:UM5MD$6!G!503GO6>'BXTXJ>_*D_7DHQ?XPE_3(JQO-N.W,VO3GJM?A*/
M](^/]=_9X;]JO_@L]\4H/$GC+QU:>%?A;H?A+Q+IOA_2-9FL;2ZU'-V0\X0_
MO(]L15HONONR<X%?G[\,?BM^T=^U#91?M#>#?A+^U#KWQ6UC6I]2T'7['Q9:
M+X+BM8[QXAI_]EE@&MQ;J\#EAYFXLV<@5^X7@?\ 9;T?P)^U/X^^+%O?7\VL
M?$#2M+TF\M)-OV>".P\[RV3C.YO/;=GT%?->O?\ !"WP7J'Q5U2]TSXE_%CP
MY\-=>UIO$&J?#?2M:-KX?O+MY!-(0% DC1YE61D1@N01T)JL.G&<.;S^3<[W
M\[Q27DERVLW:ZDE*,]+WY?N4+-=OB;>OKN>9^._V>-3_ ."MG[??QH\(^/OB
M!\0_ OA?X*Z-X?L=&\/>$]<DTMEU'4;%KR;4+AH_FD9"WDJA.PB/UKQO]OCX
MG_%R]A_9[_9YU#5/B!^T&EQX:U;6?%U_\*-:@T74?%S6-VEM;E[IF_=B$E'G
M$;;FE4 @+N%?;W[8?_!)'P[^T[\65\?>&?B#\0O@WXTO-*30M8U7P;J M7UZ
MPC_U4-RK JVSHKXW <9Q4?Q1_P""-'PO\2_ 'X<^"?!-_P")_A7J'PC\W_A$
M?$WAJ]\K5]*\\_Z7F5@?-^T9<R;P=S/NZ@4.S2TTNKKN]?>UVU:E;?3EO:,6
MWS?-\MD^VD;K3O9J^WVMVT?$^C^+?CE\,O\ @E#\:M#\9>%_BM\-]#\+^+?#
MX\ S>,-9CO/$"Z;<7]H)K62[A;,JQ2!PKM\Q28*<XKW#]H3]J_7/^"=7QR_:
MFMKV^O\ 4[/QIX.LO'O@"UGF:3&K2^7H\UE#N)P#=M92;%Z>>QQUKVS0?^"1
M?A+3OV2_%'POU/QIX]\37GCC6+77/$'BG6=1-WJVIW-O/#-&3N^2- (438B@
M8R>IS7=_M7_\$]/!/[8/Q9^$/C#Q1)?K?_!W7!K>G10,!%J##8ZPW (^:,2Q
M0R;?[T8JJD5.I:3]V5HR:WY7&*;7FI)2N]6UYF5-N$;I:J[2>UU)R2[6<6X^
M2?6Q^;G[>D/Q)^'?BC]GK]E.+0_C;\4-)T+X9OXI\66G@+Q)'I6M>(K];B.W
M$DU[,?,%O#-O<JC;F:6,'Y0:^QO^"(EY\8M,^!WC#PS\4O!OQ"\(Z+X9U[R?
M!">-KZ&^UMM'>%&6">XB)$Q@DWHLC89D*9R037J'[='_  3I\._MMWOA?7AX
MH\6?#KX@>"6F&A>+O"]V+74[&&<*MQ!D@J\4BJ 58$ @$8-=)^Q9^QKH_P"Q
M9\-+[1+#Q!XJ\8:MKFH2:MK>O^(M0>\U#5[MP TKD_*@PH 1 %&.G)K2E4_B
M2FM97^;<U)->D?=N]4E9:/0JQNX*.T4O72+3N_.7O::-N[U6OPE+^Q5=_P#!
M1/\ X*(_M7:!XH^+GQ+\,>&/ NJZ3+H>D^&]=DT_['?W&E18O'*G+1H$(6'A
M"SR$\XKQ+XU?MO\ Q;_:2_8__95^'MQIOQ.^(MU\0?\ A)1XK7P#JL.C:[XK
MAT*[-I$RW+X$22$)/+L(9MN!P37OLG_!*S5/VK?^"A?[47B34/%GQ8^$L.J:
MMH]C;ZKX;OOL,7BK2SIB">V;((=!*"-ZX926 /-?4?QV_P""4?PW^+/[.O@'
MX?\ A^XU[X;R?"=HW\%Z_P"&[K[/JGAYU3RW:.0YW^8A8.'R'+$GGFN:G&U"
M"?\ <;7>R=WKZK3K;E=DHLVE)>WE)?WE?M=6MIYZWZ;K5R1\!^'/$?QV^#?_
M  2F_:JT77/"?Q?^%_A7PW86=[\/+GQOK<6I:]8&61/M,(NXFW2QI,N]2_S
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M/2O _P#@F1_R9KX>_P"PCJ__ *=+NJCI>2W5BY?PK?WE^4CWRBBBI("BBB@
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M);EKB-VQF..9)\(P&5/48%:'Q!_X)7_$#XT)XB\8^+K7P-JWBR?XD0^/=/\
M#TDTW]F3VYT==,FT^:9=KAMI9UE7HRH2,9%?1'_#2'[0'_1M<?\ X<33_P#X
MW1_PTA^T!_T;7'_X<33_ /XW6DGS.4GO)N7S<HR;^;C'RLK=7>.5:>22^2BX
MI?=)^=W?M:[_ ,$^/V7M0_9E^''B)=6T7PCX=U+Q5K<FJG2O#L+?9=-A$4<,
M,+3.2]Q($BW-(V.7*@!5%=WX;_91^'OA#XQWOQ TWPO96OC+43(;G5%DD,LO
MF !\@L5Y '05YO\ \-(?M ?]&UQ_^'$T_P#^-T?\-(?M ?\ 1M<?_AQ-/_\
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MB3XFT_X?67@G6+?7+BYM+2UNK.:YE@U"!HF!9#]I=7B;J%3!&#GZH_X:0_:
M_P"C:X__  XFG_\ QNC_ (:0_: _Z-KC_P##B:?_ /&ZB-.,81IK:.WI:2M_
MY-+SN[IZ*U2DW.4WO+5^MT[_ /DL?*RU6KOZI^S?\(Q\ _@'X/\ !?F6,S>&
M=)M]/DELK-;.WE>- '>.%<B-6;)"@\ XK+_9:L(-.\ :K';PQPHWB'5)"J#
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M2?PW;:EK5CXZ\)^-OA?>:3X=NO%,4?B.Q6%=1L+49N7A=&9"\68]R,0W[U,
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MYX5\-^'UU$!;L:;ID-J+H#. _EJ-V-S=<]3ZUTE% '(']GSP"W]F9\#^$/\
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M^U2444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
'!1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %_ C<# 2(  A$! Q$!_\0
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MB@#RK_AD[X(?]$;^'_\ X2]C_P#&J/\ AD[X(?\ 1&_A_P#^$O8__&J]5HH
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M_P#&J/\ AD[X(?\ 1&_A_P#^$O8__&J]5HH \J_X9.^"'_1&_A__ .$O8_\
MQJC_ (9.^"'_ $1OX?\ _A+V/_QJO5:* /*O^&3O@A_T1OX?_P#A+V/_ ,:H
M_P"&3O@A_P!$;^'_ /X2]C_\:KU6B@#RK_AD[X(?]$;^'_\ X2]C_P#&J/\
MAD[X(?\ 1&_A_P#^$O8__&J]5HH \J_X9.^"'_1&_A__ .$O8_\ QJC_ (9.
M^"'_ $1OX?\ _A+V/_QJO5:* /*O^&3O@A_T1OX?_P#A+V/_ ,:H_P"&3O@A
M_P!$;^'_ /X2]C_\:KU6B@#RK_AD[X(?]$;^'_\ X2]C_P#&J/\ AD[X(?\
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M=>I:_%_5+K4E\,ZIK$&JV$>CZ)K6GM<:E+;%8<RV,GF_N@KF=RRQ-\T3%F
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M&_\ Z*'\/_\ P@[[_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\
MZ*'\/_\ P@[[_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\
M/_\ P@[[_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\
MP@[[_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[
M_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7
M-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_"
M.?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_".?&_
M_HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_".?&__HH?
MP_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_".?&__HH?P_\
M_"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_".?&__HH?P_\ _"#O
MO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_".?&__HH?P_\ _"#OO_ES
M0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK
M17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7
M_".?&_\ Z*'\/_\ P@[[_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?
M&_\ Z*'\/_\ P@[[_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\
MZ*'\/_\ P@[[_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\
M/_\ P@[[_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\
MP@[[_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[
M_P"7-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7
M-'_".?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_"
M.?&__HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_".?&_
M_HH?P_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_".?&__HH?
MP_\ _"#OO_ES0!ZK17E7_".?&_\ Z*'\/_\ P@[[_P"7-'_".?&__HH?P_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 >;?%J^33[_29F=498BR9."2+ZP; ]3@$_@:I^'/\ DZ;XA_\
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M0_\ R#7JM% 'E7_#2WA'_H$?$#_PW'B'_P"0:/\ AI;PC_T"/B!_X;CQ#_\
M(->JT4 >5?\ #2WA'_H$?$#_ ,-QXA_^0:/^&EO"/_0(^('_ (;CQ#_\@UZK
M10!Y5_PTMX1_Z!'Q _\ #<>(?_D&C_AI;PC_ - CX@?^&X\0_P#R#7JM% 'E
M7_#2WA'_ *!'Q _\-QXA_P#D&C_AI;PC_P! CX@?^&X\0_\ R#7JM% 'E7_#
M2WA'_H$?$#_PW'B'_P"0:/\ AI;PC_T"/B!_X;CQ#_\ (->JT4 >5?\ #2WA
M'_H$?$#_ ,-QXA_^0:/^&EO"/_0(^('_ (;CQ#_\@UZK10!Y5_PTMX1_Z!'Q
M _\ #<>(?_D&C_AI;PC_ - CX@?^&X\0_P#R#7JM% 'E7_#2WA'_ *!'Q _\
M-QXA_P#D&C_AI;PC_P! CX@?^&X\0_\ R#7JM% 'E7_#2WA'_H$?$#_PW'B'
M_P"0:/\ AI;PC_T"/B!_X;CQ#_\ (->JT4 >5?\ #2WA'_H$?$#_ ,-QXA_^
M0:/^&EO"/_0(^('_ (;CQ#_\@UZK10!Y5_PTMX1_Z!'Q _\ #<>(?_D&C_AI
M;PC_ - CX@?^&X\0_P#R#7JM% 'E7_#2WA'_ *!'Q _\-QXA_P#D&C_AI;PC
M_P! CX@?^&X\0_\ R#7JM% 'E7_#2WA'_H$?$#_PW'B'_P"0:/\ AI;PC_T"
M/B!_X;CQ#_\ (->JT4 >5?\ #2WA'_H$?$#_ ,-QXA_^0:/^&EO"/_0(^('_
M (;CQ#_\@UZK10!Y5_PTMX1_Z!'Q _\ #<>(?_D&C_AI;PC_ - CX@?^&X\0
M_P#R#7JM% 'E7_#2WA'_ *!'Q _\-QXA_P#D&C_AI;PC_P! CX@?^&X\0_\
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M?$#_ ,-QXA_^0:/^&EO"/_0(^('_ (;CQ#_\@UZK10!Y5_PTMX1_Z!'Q _\
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MBBB@#RKX-_\ )1?CM_V.=M_ZCVC5ZK7E7P;_ .2B_';_ +'.V_\ 4>T:O5:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH X_1=$BU;P=KUBFVV;4;O4X9)E
M0$Y:XF3<>FX@8ZGH *\E_9_OKB3X]?$6U>>5[6/PAX1E2!G)17>/40[!>@+!
M$!/?:OH*]H\!2^?X?>7^_?WS?G=S&O /V7=2DU;X[?$V>2,1E?"WA> !<X(B
MDU:,'\0F?K7B1Y/:X:V[B_P2_P S+2\3ZAHHHKVS4**** "BBB@ HHK&UCQA
MI&@:MI.F7UWY-_JLC16<(C=S(P&3G:"%'3YFP,D#.2!0!LT5REK\4/#EYXD&
MAQ7DYOFGDM4D:QN%MI)D!+Q)<%!"[J%;*JY(*,,94XZN@#RKX-_\E%^.W_8Y
MVW_J/:-7JM>5?!O_ )*+\=O^QSMO_4>T:O5: "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHKREOBU9>'_$WC>!XY+N"S(NP\;?Q!+> Q<]/WAZ]N3S7)B,53PW
M*ZKLG_DW^A,I*.YV_@-A)X0TR53E9HO.!]=Q+9_6O)?@W9PZ=^T%\1+2VC$5
MO!X:T>*.,=%5=8\1@#\ *]E\*Z:^C>&=(L)<>;:VD4+XZ;E0 _J*\O\  >EC
M1_VF_B/ )/-W^%=!N-VW&/-U/Q!)C\-^/?%32IM>S;6T;?\ I/\ D"6Q[)11
M17:4%%%% !1110 5Y)XN^''C"Z\<VVMZ=K6EW-K)JUK.8;K2V::SMXHG78)1
M<H&3<SM@)NW2YR0,5ZW10!X[HOAGQ-&NA^&;G09([72M<EU.37Y+F!K>:'SI
M94$:"0S>8WF*I#(JC#_,>-WHGC+P[J'BC2!9Z;XHU;PC<"59/[0T:*TDG*@'
M*8NH)X]IR"?DSP,$<YWJ* /E_P"$_P )_%%UX\^,\47QG\<6;VWBVWBEFAL]
M"+73'0M)?S)-^F, P5UCP@1=L:_+N+,WI?\ PIOQ=_T7;X@?^ /A[_Y54?!O
M_DHOQV_['.V_]1[1J]5H \J_X4WXN_Z+M\0/_ 'P]_\ *JC_ (4WXN_Z+M\0
M/_ 'P]_\JJ]5HH \J_X4WXN_Z+M\0/\ P!\/?_*JC_A3?B[_ *+M\0/_  !\
M/?\ RJKU6B@#RK_A3?B[_HNWQ _\ ?#W_P JJ/\ A3?B[_HNWQ _\ ?#W_RJ
MKU6B@#RK_A3?B[_HNWQ _P# 'P]_\JJ/^%-^+O\ HNWQ _\  'P]_P#*JO5:
M* /*O^%-^+O^B[?$#_P!\/?_ "JH_P"%-^+O^B[?$#_P!\/?_*JO5:* /*O^
M%-^+O^B[?$#_ , ?#W_RJH_X4WXN_P"B[?$#_P  ?#W_ ,JJ]5HH \J_X4WX
MN_Z+M\0/_ 'P]_\ *JC_ (4WXN_Z+M\0/_ 'P]_\JJ]5HH \J_X4WXN_Z+M\
M0/\ P!\/?_*JC_A3?B[_ *+M\0/_  !\/?\ RJKU6B@#RK_A3?B[_HNWQ _\
M ?#W_P JJ/\ A3?B[_HNWQ _\ ?#W_RJKU6B@#RK_A3?B[_HNWQ _P# 'P]_
M\JJ/^%-^+O\ HNWQ _\  'P]_P#*JO5:* /*O^%-^+O^B[?$#_P!\/?_ "JH
M_P"%-^+O^B[?$#_P!\/?_*JO5:* /*O^%-^+O^B[?$#_ , ?#W_RJH_X4WXN
M_P"B[?$#_P  ?#W_ ,JJ]5HH \J_X4WXN_Z+M\0/_ 'P]_\ *JC_ (4WXN_Z
M+M\0/_ 'P]_\JJ]5HH \J_X4WXN_Z+M\0/\ P!\/?_*JC_A3?B[_ *+M\0/_
M  !\/?\ RJKU6B@#RK_A3?B[_HNWQ _\ ?#W_P JJ/\ A3?B[_HNWQ _\ ?#
MW_RJKU6B@#RK_A3?B[_HNWQ _P# 'P]_\JJ/^%-^+O\ HNWQ _\  'P]_P#*
MJO5:* /*O^%-^+O^B[?$#_P!\/?_ "JH_P"%-^+O^B[?$#_P!\/?_*JO5:*
M/*O^%-^+O^B[?$#_ , ?#W_RJH_X4WXN_P"B[?$#_P  ?#W_ ,JJ]5HH \J_
MX4WXN_Z+M\0/_ 'P]_\ *JC_ (4WXN_Z+M\0/_ 'P]_\JJ]5HH \J_X4WXN_
MZ+M\0/\ P!\/?_*JC_A3?B[_ *+M\0/_  !\/?\ RJKU6B@#RK_A3?B[_HNW
MQ _\ ?#W_P JJ/\ A3?B[_HNWQ _\ ?#W_RJKU6B@#RK_A3?B[_HNWQ _P#
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MD\7?]$)^('_@=X>_^6M'_"Y/%W_1"?B!_P"!WA[_ .6M 'JM%>5?\+D\7?\
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M_P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5=11ZK17E7_#)WP0_Z(W\/_\
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M_P#_  E['_XU1_PR=\$/^B-_#_\ \)>Q_P#C5 'JM%>5?\,G?!#_ *(W\/\
M_P )>Q_^-4?\,G?!#_HC?P__ /"7L?\ XU0!ZK17E7_#)WP0_P"B-_#_ /\
M"7L?_C5'_#)WP0_Z(W\/_P#PE['_ .-4 >I2RI#&\DCK'&@+,[' 4#J2?2N
M^*V?$6FZ;HUE-(QN-;M[*[-ODO$-AE8_55"MGMBO,_B5\(?@?\.8D2V^$?@V
MQUB>VFEL+_3_  W91RVMPN/*D5A&&0ACN#*<@KQ53P'^SCX+\1:II%[K/PS\
M.)I$^DS@V;Z);?9P/M>Z.U,;1G$(!CE2/[N\;QR":\/%8F-:H\%#6]N;R3>O
MYHRE*[Y3TS2_"\G@?QEX;OYY+18KK3(="G96(9[A4+A^0,@B%5&>>@Q76W$J
M3^-M%DC=9(VTR\974Y!!DM<$'TKS;Q9^S-\-M'\(ZVWA/X8>#])U6:U\LOIO
MAZTBDGBWJSPG9&"RN%VE#D-G!!K#\"_L[_#G4M8U_2/$OPV\%ZO>62VKW<LN
M@VLL=S<N9W-P=T7S2LCQAG;YB0<DTXKZO66%C'W9--/SWM_Y*V'POE/H6N'^
M+U])H_AJ'5$C9TL99'<J1E?,MYH4/)&1YDJ9QS@D]JPO^&3O@A_T1OX?_P#A
M+V/_ ,:J.;]EKX4Z>8;G0/AGX-T'4XIXF6_T[0K:UG2/S%\U4EBC#J6CWIP1
MD,1T)KT<5"52A.,/BMIZ]/Q+EJM#MOA_X=D\)^%;?29-Q^S37"HS$$M&9G*,
M<=RI4_C7!>-/-;QSJ=NY9+73[9?$B[0/FEC$<0SQT"J_3OCTJW_PR=\$/^B-
M_#__ ,)>Q_\ C59.H_LN?#F!M5&D_##P=9^39++HYM]#M(OLM^?-W3180>5(
M=MMF08)\M.?D&.3%8;]Q"C3VC^B=B91T21TOQ6U+6[6[M/["U..R>SL;K4KJ
M%SD2QQ-"0I&#U^8#IGYAGK7/:1XJB\'R:,T:ION/#]E=3P*H#3I#:7CL<XZY
M2%<^F!TK@?@G\"O!?B:WOH[OP'X=TS3K)5EM[>ST.W@B6]D+.M[$HC"I<)&4
M59%7<%*8('7L_%G[-/AC^V+2ZT?P]I%CH\EW;W%_IEEIT:?:KG[5&6NGVK\T
MH&',I^<&%#G(!7QVZ^(7UZ@GJU9/HEH]/S[^9GK+WT:GPM^)5SXC\5:Q:3SR
M'3<W>H0S76!B#S(EB49^Z%'F9YQS[5;3P5)J'@'^VM(8Q>([X-J\4S.0(I9U
MC:5$P. 0@ SDY YY-4O%W[,OA+Q NB_9-)TNSDL;F.YGF_LZ'S[F0+'']H:4
M+GSUB1E$F"?FQD FM&^_9<^#&IWEQ>7GPC\"7=W<2-+-<3^&K)Y)'8Y9F8Q9
M)))))Y)-=^'PE:<72Q6MEH_-VV[<MM/O*47M([J\\0P6_A:?78E,]M'9M>JJ
MG!= F\#/N*\O\41+\2-+US4])U!HBNJVVE0R*H*21;?*;D=BUY*<\Y4+P*\Y
MTG]E7_A(-22^N?#^A>'IK6Y4G_08S*)MB[[J,JN"\A>1F<,"6=\GDUZO+^R_
M\+=4N[FYU_P#X9\43O)^XGUS1K>]FMX<#$*R2JS; V]@,\%S[DY1>(S'W:M/
MEAY[WLU=+?Y/_,-9[K0[_P .^&=/\*V"6>GP>7$FX*6Y8*9'<)NZE07;&?7Z
MFM6O*O\ AD[X(?\ 1&_A_P#^$O8__&J/^&3O@A_T1OX?_P#A+V/_ ,:KZ"$(
MTXJ,%9(VV/5:*\J_X9.^"'_1&_A__P"$O8__ !JC_AD[X(?]$;^'_P#X2]C_
M /&JL#U6BO*O^&3O@A_T1OX?_P#A+V/_ ,:H_P"&3O@A_P!$;^'_ /X2]C_\
M:H ]5HKRK_AD[X(?]$;^'_\ X2]C_P#&J/\ AD[X(?\ 1&_A_P#^$O8__&J
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MDP<82@Z\8V<]7][M]Q,;6OW"LW3=%CTW4M7O0V^74)TE;Y<;0L21A??[A/\
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M:K7S70ER1Z56##_I'CJ[\SG['IL/D_[/G2R^9]<^1%]-ON:I:;X[M+5I=/\
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MIH)=3^%7PWO9(65D>7QS>D\9P"?[&Y7YC\IR.>E:_P#PDGQO_P"B>?#_ /\
M"\OO_E-7JM%4H1BW)+5[C/*O^$D^-_\ T3SX?_\ A>7W_P IJ/\ A)/C?_T3
MSX?_ /A>7W_RFKU6BK \J_X23XW_ /1//A__ .%Y??\ RFH_X23XW_\ 1//A
M_P#^%Y??_*:O5:* /*O^$D^-_P#T3SX?_P#A>7W_ ,IJ/^$D^-__ $3SX?\
M_A>7W_RFKU6B@#RK_A)/C?\ ]$\^'_\ X7E]_P#*:C_A)/C?_P!$\^'_ /X7
ME]_\IJ]5HH \J_X23XW_ /1//A__ .%Y??\ RFH_X23XW_\ 1//A_P#^%Y??
M_*:O5:* /*O^$D^-_P#T3SX?_P#A>7W_ ,IJ/^$D^-__ $3SX?\ _A>7W_RF
MKU6B@#RK_A)/C?\ ]$\^'_\ X7E]_P#*:C_A)/C?_P!$\^'_ /X7E]_\IJ]5
MHH \J_X23XW_ /1//A__ .%Y??\ RFH_X23XW_\ 1//A_P#^%Y??_*:O5:*
M/*O^$D^-_P#T3SX?_P#A>7W_ ,IJ/^$D^-__ $3SX?\ _A>7W_RFKU6B@#RK
M_A)/C?\ ]$\^'_\ X7E]_P#*:C_A)/C?_P!$\^'_ /X7E]_\IJ]5HH \J_X2
M3XW_ /1//A__ .%Y??\ RFH_X23XW_\ 1//A_P#^%Y??_*:O5:* /*O^$D^-
M_P#T3SX?_P#A>7W_ ,IJ/^$D^-__ $3SX?\ _A>7W_RFKU6B@#RK_A)/C?\
M]$\^'_\ X7E]_P#*:C_A)/C?_P!$\^'_ /X7E]_\IJ]5HH \J_X23XW_ /1/
M/A__ .%Y??\ RFKG_A/?>*K[]I+XD2>+M&T?0]2'A+PVL=OHFK2ZE"T7VS7,
M.9)+6W(;<7&W80  =QR0/=:\J\.?\G3?$/\ [$SPS_Z7:]0!ZK1110 4444
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M_P#_  J+'_X[1_PUC\$/^BR?#_\ \*BQ_P#CM 'JM%>5?\-8_!#_ *+)\/\
M_P *BQ_^.T?\-8_!#_HLGP__ /"HL?\ X[0!ZK17E7_#6/P0_P"BR?#_ /\
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M_P#CM 'JM%>5?\-8_!#_ *+)\/\ _P *BQ_^.T?\-8_!#_HLGP__ /"HL?\
MX[0!ZK17E7_#6/P0_P"BR?#_ /\ "HL?_CM'_#6/P0_Z+)\/_P#PJ+'_ ..T
M >JT5Y5_PUC\$/\ HLGP_P#_  J+'_X[1_PUC\$/^BR?#_\ \*BQ_P#CM 'J
MM%>5?\-8_!#_ *+)\/\ _P *BQ_^.T?\-8_!#_HLGP__ /"HL?\ X[0!ZK17
ME7_#6/P0_P"BR?#_ /\ "HL?_CM'_#6/P0_Z+)\/_P#PJ+'_ ..T >JT5Y5_
MPUC\$/\ HLGP_P#_  J+'_X[1_PUC\$/^BR?#_\ \*BQ_P#CM 'JM%>5?\-8
M_!#_ *+)\/\ _P *BQ_^.T?\-8_!#_HLGP__ /"HL?\ X[0!ZK17E7_#6/P0
M_P"BR?#_ /\ "HL?_CM'_#6/P0_Z+)\/_P#PJ+'_ ..T >JT5Y5_PUC\$/\
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M'J%G/:S M#/&T3@'!*L,']#4]% 'GWA'X:ZKH>H:*^J^(8M5L=!M7M-+MX+
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M:AXHFEGO+NX=98;>8@PVL@A2%I(UQ]]D11N.2!D# 9LZWBSQ/9^"_#6HZYJ
MF-E80M/+Y$32/M'HJ@GZGH!DG !-'BJ\U?3]%FNM$L(M4OX2KBSEE\HS("-Z
MHW0.5SMSQG&2!S7B>N^+M=U?Q)I.M>$]2U+4)KZ1U73;BVF^PC;)'$]A/&H*
MV\B!I)'FD^<%<*&7Y: .Y\/^./$>L>+-'TS5[.ST".>W>_C>SF-[#J4>P;8X
MYBB!&3=N<$9.U2F5+8Z7PO\ #_2/">J:MJ5FDLM]J5Q)/+/<R;V0/(TABC_N
M1[V9MH[L2<FK?A/PK8^#M,>PTU'M[)I6FCM?,+QV^[!,<6?NQ@Y(4<#)P ,
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MF,GSJ<* =GI5BOQB^'LZ:S>W,4=[?+.8;)6M)[ P7".MN21N#J\(#MP22VW
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M< !47<<* .26.68DS?#OP6O@3PK::5YWVB2+>[%=PCC9VW,D*DDI$#PJ9P
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M<'E?A/H^J^-((7\01WTMGI4T5[I>HWPGM]2L;AN9K,O(H:>-5*QM*>'RRD'
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MB\QS(^Q0-S'JQQU/ YJ6BB@#%\8>$[/QMH4FD7\DR64LD;RK"5#.$=7"Y(.
M2HY7##L0>:VJ** "HKBUAO(6AN(HYXFP3'(H93@Y'!]P*EHH **** ,:W\*V
MEOXNO/$>^5]0N;2.RPQ4(D2,S@   G+.3EB?;'.=FBB@ J(6L*W+7 AC%PR"
G-I=HWE020I/7 )/'N:EHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  V .D# 2(  A$! Q$!_\0
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MO?+F4H)"(79(=_W?,=5*QY[;B,U@7&K:)9_%G3[<7]A#*=,NT>,2HI\UYH"
M1G[S;6.#R<&N>UVXAMM.^(6@W3#^V-4N"]A ?OW2201I'Y8_BVLI!Q]W'.*
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$% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Dec. 15, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000009631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">BANK OF NOVA SCOTIA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-282565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Dec. 15, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text">The term sheet to which this Exhibit is attached is a final prospectus for the related offering.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 8,391,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ex-filingfees.htm">ex-filingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ex-filingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "ex-filingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 1,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-15",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-15",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-15",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-15",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001839882-25-071122-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001839882-25-071122-xbrl.zip
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M(@:?L-U2I<:YYMJW/AL9G#7L8;+O[O'<?K0UVR\7?I?OP@NS<XG.>5'W/)O
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M_P=02P$"% ,4    "  Z?H];3K1E _<(  !1(   $0              @ $
J    97@M9FEL:6YG9F5E<RYH=&U02P4&      $  0 _    )@D

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ex-filingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="AsOf2025-12-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000009631</identifier>
        </entity>
        <period>
            <startDate>2025-12-15</startDate>
            <endDate>2025-12-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-12-15" id="Fact000003">0000009631</dei:EntityCentralIndexKey>
    <ffd:FormTp contextRef="AsOf2025-12-15" id="Fact000009">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="AsOf2025-12-15" id="Fact000010">BANK OF NOVA SCOTIA</dei:EntityRegistrantName>
    <ffd:SubmissnTp contextRef="AsOf2025-12-15" id="Fact000011">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="AsOf2025-12-15" id="Fact000012">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:RegnFileNb contextRef="AsOf2025-12-15" id="Fact000013">333-282565</ffd:RegnFileNb>
    <ffd:FnlPrspctsFlg contextRef="AsOf2025-12-15" id="Fact000014">true</ffd:FnlPrspctsFlg>
    <ffd:OfferingTableNa contextRef="AsOf2025-12-15" id="Fact000015">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="AsOf2025-12-15" id="Fact000016">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="AsOf2025-12-15" id="Fact000017">N/A</ffd:CombinedProspectusTableNa>
    <ffd:NrrtvDsclsr contextRef="AsOf2025-12-15" id="Fact000018">The term sheet to which this Exhibit is attached is a final prospectus for the related offering.</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="AsOf2025-12-15"
      decimals="0"
      id="Fact000019"
      unitRef="USD">8391420</ffd:NrrtvMaxAggtOfferingPric>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
